_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
503223445,7/15/2014 10:53:13,,1323505308,7/15/2014 10:53:05,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,JC VIRUS ISOLATES causes MULTIFOCAL LEUKOENCEPHALOPATHY,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223445,7/15/2014 12:14:24,,1323552091,7/15/2014 12:14:02,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,JC VIRUS ISOLATES causes MULTIFOCAL LEUKOENCEPHALOPATHY,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223445,7/15/2014 13:15:09,,1323575229,7/15/2014 13:14:18,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,JC VIRUS ISOLATES causes MULTIFOCAL LEUKOENCEPHALOPATHY,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223445,7/15/2014 18:54:32,,1323784624,7/15/2014 18:54:16,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,MULTIFOCAL LEUKOENCEPHALOPATHY causes JC VIRUS ISOLATES,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223445,7/15/2014 19:05:55,,1323790926,7/15/2014 19:05:04,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223445,7/15/2014 21:31:22,,1323851912,7/15/2014 21:30:32,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,JC VIRUS ISOLATES causes MULTIFOCAL LEUKOENCEPHALOPATHY,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223445,7/15/2014 22:16:35,,1323869569,7/15/2014 22:16:07,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,JC VIRUS ISOLATES causes MULTIFOCAL LEUKOENCEPHALOPATHY,149,225,,165,255,causes,0.811107105653813,903673-FS1-4,"To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC VIRUS ISOLATES amplified from AIDS patients with and without progressive MULTIFOCAL LEUKOENCEPHALOPATHY and healthy controls by nucleotide sequencing.",JC VIRUS ISOLATES,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-has_causative_agent
503223446,7/15/2014 10:30:12,,1323489266,7/15/2014 10:30:04,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,FUNCTIONAL LIVER BLOOD FLOW treats LIVER ATROPHY,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223446,7/15/2014 10:33:19,,1323491333,7/15/2014 10:32:37,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223446,7/15/2014 16:47:06,,1323697767,7/15/2014 16:46:58,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,FUNCTIONAL LIVER BLOOD FLOW treats LIVER ATROPHY,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223446,7/15/2014 17:14:50,,1323724645,7/15/2014 17:14:20,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,no_relation,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223446,7/15/2014 17:58:41,,1323761152,7/15/2014 17:58:22,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,FUNCTIONAL LIVER BLOOD FLOW treats LIVER ATROPHY,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223446,7/15/2014 18:48:22,,1323781292,7/15/2014 18:47:49,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,no_relation,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223446,7/15/2014 18:51:00,,1323782698,7/15/2014 18:50:55,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,FUNCTIONAL LIVER BLOOD FLOW treats LIVER ATROPHY,95,135,,121,148,treats,0.943456353049726,905234-FS1-2,"These results suggest that in the cirrhotic rat, selective portasystemic shunts which preserve FUNCTIONAL LIVER BLOOD FLOW and prevent LIVER ATROPHY and a deterioration in liver function do not produce such a marked decrease in WHVP as total shunts.",FUNCTIONAL LIVER BLOOD FLOW,LIVER ATROPHY,RO-has_finding_site
503223447,7/15/2014 10:52:41,,1323504924,7/15/2014 10:52:32,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,DEXAMETHASONE treats HYPERCORTISOLISM,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223447,7/15/2014 11:11:21,,1323518331,7/15/2014 11:10:49,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223447,7/15/2014 11:40:53,,1323535738,7/15/2014 11:40:20,clixsense,0.5,23233834,GBR,N6,Sunderland,86.17.58.181,DEXAMETHASONE treats HYPERCORTISOLISM,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223447,7/15/2014 13:07:33,,1323572613,7/15/2014 13:07:22,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,HYPERCORTISOLISM treats DEXAMETHASONE,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223447,7/15/2014 14:33:42,,1323599395,7/15/2014 14:33:36,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,HYPERCORTISOLISM treats DEXAMETHASONE,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223447,7/15/2014 19:11:49,,1323794046,7/15/2014 19:11:19,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223447,7/15/2014 19:55:32,,1323812302,7/15/2014 19:54:52,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,64,103,,79,116,treats,0.547722557505166,906872-FS1-2,In MDD there are two well documented biochemical abnormalities: HYPERCORTISOLISM and its resistance to DEXAMETHASONE suppression.,HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503223448,7/15/2014 10:10:15,,1323476700,7/15/2014 10:09:26,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223448,7/15/2014 10:53:04,,1323505178,7/15/2014 10:52:55,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,no_relation,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223448,7/15/2014 11:11:53,,1323518706,7/15/2014 11:11:22,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223448,7/15/2014 11:35:16,,1323532534,7/15/2014 11:34:47,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223448,7/15/2014 15:53:39,,1323644013,7/15/2014 15:53:22,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,WITH HEPATOCELLULAR CARC diagnosed by STERILE CIRRHOTIC AS,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223448,7/15/2014 17:58:06,,1323760756,7/15/2014 17:57:51,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,WITH HEPATOCELLULAR CARC diagnosed by STERILE CIRRHOTIC AS,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223448,7/15/2014 18:48:46,,1323781547,7/15/2014 18:48:23,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,no_relation,186,278,,205,302,diagnosed by,0.493196961916072,902776-FS1-13,"To define patients with an ascitic fluid polymorphonuclear cell count &gt; or = 250 cells/mm3 or &gt; or = 500 cells/mm3 but without spontaneous bacterial peritonitis, 166 patients with STERILE CIRRHOTIC AScites, 46 patients with spontaneous bacterial peritonitis, 123 patients WITH HEPATOCELLULAR CARCinoma, 67 patients with peritoneal carcinomatosis or massive liver metastasis and 12 patients with other miscellaneous diseases were studied.",STERILE CIRRHOTIC AS,WITH HEPATOCELLULAR CARC,RO-disease_may_have_finding
503223449,7/15/2014 13:06:56,,1323572411,7/15/2014 13:06:44,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,FORMALDEHYDE CONCENTRATION causes FORMALDEHYDE TOXICITY,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223449,7/15/2014 16:46:57,,1323697641,7/15/2014 16:46:50,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,FORMALDEHYDE TOXICITY causes FORMALDEHYDE CONCENTRATION,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223449,7/15/2014 17:00:27,,1323712658,7/15/2014 17:00:07,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223449,7/15/2014 17:23:09,,1323728821,7/15/2014 17:22:42,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,FORMALDEHYDE TOXICITY causes FORMALDEHYDE CONCENTRATION,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223449,7/15/2014 17:55:52,,1323758697,7/15/2014 17:55:28,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,FORMALDEHYDE CONCENTRATION causes FORMALDEHYDE TOXICITY,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223449,7/15/2014 18:47:47,,1323780937,7/15/2014 18:46:55,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,FORMALDEHYDE CONCENTRATION causes FORMALDEHYDE TOXICITY,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223449,7/16/2014 01:44:34,,1323979959,7/16/2014 01:44:08,clixsense,0.7798,19638651,USA,"","",173.23.121.63,no_relation,61,0,,86,21,causes,0.676123403782813,903610-FS1-4,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223450,7/15/2014 10:27:33,,1323487480,7/15/2014 10:26:57,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 10:55:52,,1323506985,7/15/2014 10:55:30,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 11:22:05,,1323525004,7/15/2014 11:21:46,instagc,0.9417,13763729,USA,"","",75.182.89.225,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 12:40:32,,1323561891,7/15/2014 12:40:21,instagc,0.7417,18960682,GBR,"","",86.29.147.112,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 12:55:55,,1323567998,7/15/2014 12:55:30,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 14:22:48,,1323596011,7/15/2014 14:22:22,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 15:57:18,,1323646877,7/15/2014 15:56:51,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.995037190209989,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223451,7/15/2014 10:10:55,,1323477055,7/15/2014 10:10:34,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,TUBERCULIN treats TUBERCULOSIS,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 11:25:02,,1323526696,7/15/2014 11:24:09,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 12:15:27,,1323552505,7/15/2014 12:14:59,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,TUBERCULIN treats TUBERCULOSIS,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 15:17:34,,1323618150,7/15/2014 15:16:42,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 17:00:05,,1323712291,7/15/2014 16:59:50,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 18:54:38,,1323784682,7/15/2014 18:54:34,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,TUBERCULIN treats TUBERCULOSIS,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 19:13:34,,1323794909,7/15/2014 19:13:03,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,137,84,,148,94,treats,0.674199862463242,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223452,7/15/2014 11:12:19,,1323518998,7/15/2014 11:11:54,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 11:21:46,,1323524860,7/15/2014 11:21:23,instagc,0.9417,13763729,USA,"","",75.182.89.225,no_relation,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 14:23:15,,1323596115,7/15/2014 14:22:51,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 14:34:03,,1323599519,7/15/2014 14:33:58,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,CARIES causes FETAL FLUORIDE,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 16:24:54,,1323671153,7/15/2014 16:24:37,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 17:10:50,,1323722046,7/15/2014 17:10:08,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 20:34:35,,1323828308,7/15/2014 20:33:56,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,3,35,,8,49,causes,0.344123600805843,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223453,7/15/2014 10:53:13,,1323505307,7/15/2014 10:53:05,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,DIC causes DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223453,7/15/2014 12:55:28,,1323567796,7/15/2014 12:54:59,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA causes DIC,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223453,7/15/2014 15:17:34,,1323618144,7/15/2014 15:16:42,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223453,7/15/2014 16:24:15,,1323670443,7/15/2014 16:23:59,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223453,7/15/2014 16:47:17,,1323697943,7/15/2014 16:47:08,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,DIC causes DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223453,7/15/2014 16:58:02,,1323709749,7/15/2014 16:57:41,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA causes DIC,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223453,7/15/2014 19:36:06,,1323805155,7/15/2014 19:35:45,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,no_relation,129,129,,131,174,causes,0.320256307610174,902964-FS1-4,? The efficacy of tranexamic acid in patients with hyperfibrinolysis was shown in a randomized controlled trial in patients with DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA showing resolution of DIC and fewer bleeding complications in comparison with placebo ( 60.,DIC,DIC SECONDARY TO ACUTE PROMYELOCYTIC LEUKEMIA,RO-disease_may_have_finding
503223454,7/15/2014 10:11:30,,1323477318,7/15/2014 10:10:56,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,no_relation,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223454,7/15/2014 11:17:11,,1323522036,7/15/2014 11:16:27,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223454,7/15/2014 15:44:18,,1323637080,7/15/2014 15:43:57,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,CUTANEOUS MELANOMA treats PRIMARY MELANOMA,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223454,7/15/2014 20:36:35,,1323829052,7/15/2014 20:35:33,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223454,7/16/2014 00:36:31,,1323944232,7/16/2014 00:35:36,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,PRIMARY MELANOMA treats CUTANEOUS MELANOMA,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223454,7/16/2014 00:45:44,,1323948423,7/16/2014 00:45:15,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223454,7/16/2014 02:17:25,,1323996000,7/16/2014 02:17:21,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,CUTANEOUS MELANOMA treats PRIMARY MELANOMA,38,135,,53,153,treats,0.821994936526786,906492-FS1-2,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223455,7/15/2014 11:16:42,,1323521672,7/15/2014 11:16:11,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 15:23:28,,1323621893,7/15/2014 15:23:06,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 15:44:48,,1323637493,7/15/2014 15:44:19,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 17:57:30,,1323760320,7/15/2014 17:57:14,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,EXOGENOUS OBESITY treats PHENTERMINE,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 22:41:53,,1323881807,7/15/2014 22:41:45,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/16/2014 00:39:30,,1323945600,7/16/2014 00:38:30,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/16/2014 01:09:44,,1323962528,7/16/2014 01:09:25,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.983078304622849,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223456,7/15/2014 10:32:02,,1323490540,7/15/2014 10:31:20,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223456,7/15/2014 11:10:02,,1323517348,7/15/2014 11:09:26,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223456,7/15/2014 11:17:45,,1323522502,7/15/2014 11:17:22,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223456,7/15/2014 11:25:22,,1323526823,7/15/2014 11:25:06,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223456,7/15/2014 13:07:33,,1323572612,7/15/2014 13:07:22,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,TACHYCARDIAS AND RECOGNITION OF THE SITE OF diagnosed by AL DIAGNOSIS O,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223456,7/15/2014 13:56:44,,1323588760,7/15/2014 13:55:41,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,TACHYCARDIAS AND RECOGNITION OF THE SITE OF diagnosed by AL DIAGNOSIS O,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223456,7/16/2014 00:47:23,,1323949180,7/16/2014 00:46:50,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,132,99,,174,113,diagnosed by,0.802955068546966,904502-FS1-13,This article concerns the electrocardiogram in ventricular tachycardias with two themes: differentiAL DIAGNOSIS Of wide QRS complex TACHYCARDIAS AND RECOGNITION OF THE SITE OF origin of a ventricular tachycardia.,TACHYCARDIAS AND RECOGNITION OF THE SITE OF,AL DIAGNOSIS O,RO-has_definitional_manifestation
503223457,7/15/2014 10:29:54,,1323489081,7/15/2014 10:29:41,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,NICOTINE treats NICOTINE ADDICTION,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223457,7/15/2014 10:54:34,,1323506198,7/15/2014 10:54:08,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,NICOTINE treats NICOTINE ADDICTION,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223457,7/15/2014 22:41:44,,1323881727,7/15/2014 22:41:32,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,NICOTINE ADDICTION treats NICOTINE,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223457,7/16/2014 02:17:54,,1323996287,7/16/2014 02:17:49,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,no_relation,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223457,7/16/2014 02:36:34,,1324003455,7/16/2014 02:36:07,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223457,7/16/2014 03:58:37,,1324034036,7/16/2014 03:57:54,clixsense,0.381,6330991,USA,NJ,Belvidere,69.141.104.97,NICOTINE ADDICTION treats NICOTINE,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223457,7/16/2014 05:00:18,,1324057712,7/16/2014 04:59:41,instagc,0.5714,27770607,USA,TX,El Paso,72.183.248.75,no_relation,96,96,,103,114,treats,0.339683110243379,903591-FS1-2,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223458,7/15/2014 10:32:02,,1323490539,7/15/2014 10:31:20,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 11:35:15,,1323532540,7/15/2014 11:34:54,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 15:31:57,,1323627814,7/15/2014 15:31:41,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 16:53:42,,1323704770,7/15/2014 16:53:07,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 18:48:46,,1323781550,7/15/2014 18:48:23,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/16/2014 00:45:14,,1323948209,7/16/2014 00:44:41,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/16/2014 01:10:17,,1323962868,7/16/2014 01:09:45,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223459,7/15/2014 10:31:20,,1323490092,7/15/2014 10:31:01,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 11:23:00,,1323525538,7/15/2014 11:22:34,instagc,0.9417,13763729,USA,"","",75.182.89.225,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 11:27:25,,1323528006,7/15/2014 11:27:07,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 12:41:41,,1323562285,7/15/2014 12:41:17,instagc,0.7417,18960682,GBR,"","",86.29.147.112,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 15:32:24,,1323628139,7/15/2014 15:32:07,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 16:24:36,,1323670861,7/15/2014 16:24:26,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 18:46:21,,1323780236,7/15/2014 18:45:34,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223460,7/15/2014 10:10:32,,1323476805,7/15/2014 10:10:13,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,RETINOBLASTOMA causes CALCIFICATION,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223460,7/15/2014 10:11:39,,1323477402,7/15/2014 10:11:11,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,RETINOBLASTOMA causes CALCIFICATION,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223460,7/15/2014 11:11:21,,1323518329,7/15/2014 11:10:49,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223460,7/15/2014 11:51:57,,1323542447,7/15/2014 11:51:41,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,CALCIFICATION causes RETINOBLASTOMA,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223460,7/15/2014 15:32:05,,1323627916,7/15/2014 15:31:58,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,RETINOBLASTOMA causes CALCIFICATION,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223460,7/15/2014 17:01:18,,1323713480,7/15/2014 17:00:58,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,RETINOBLASTOMA causes CALCIFICATION,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223460,7/15/2014 20:34:35,,1323828310,7/15/2014 20:33:56,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,RETINOBLASTOMA causes CALCIFICATION,123,175,,135,189,causes,0.970142500145332,902875-FS1-4,"Disagreement still exists regarding the influence of rosette formation, pseudorosettes, necrotic changes, vascularity, and CALCIFICATION on the echographic characteristics of RETINOBLASTOMA",CALCIFICATION,RETINOBLASTOMA,RO-disease_may_have_finding
503223461,7/15/2014 14:14:38,,1323593582,7/15/2014 14:13:58,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,URSODEOXYCHOLIC ACID treats GALLSTONE DISSOLUTION,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223461,7/15/2014 15:32:41,,1323628396,7/15/2014 15:32:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,URSODEOXYCHOLIC ACID treats GALLSTONE DISSOLUTION,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223461,7/15/2014 21:32:42,,1323852417,7/15/2014 21:32:22,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,URSODEOXYCHOLIC ACID treats GALLSTONE DISSOLUTION,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223461,7/15/2014 22:17:06,,1323869756,7/15/2014 22:16:55,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,URSODEOXYCHOLIC ACID treats GALLSTONE DISSOLUTION,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223461,7/16/2014 01:45:35,,1323980307,7/16/2014 01:45:23,clixsense,0.7798,19638651,USA,"","",173.23.121.63,URSODEOXYCHOLIC ACID treats GALLSTONE DISSOLUTION,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223461,7/16/2014 02:17:54,,1323996289,7/16/2014 02:17:49,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,GALLSTONE DISSOLUTION treats URSODEOXYCHOLIC ACID,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223461,7/16/2014 02:35:37,,1324003165,7/16/2014 02:35:24,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,URSODEOXYCHOLIC ACID treats GALLSTONE DISSOLUTION,123,72,,143,92,treats,0.997054485501582,908173-FS1-2,"The authors concluded that the combination of chenodeoxycholic acid and URSODEOXYCHOLIC ACID was the preferred therapy for GALLSTONE DISSOLUTION because it dissolves stones more rapidly, with a lower incidence of stone calcifications, and thus might reduce the long term cost of treatment.",GALLSTONE DISSOLUTION,URSODEOXYCHOLIC ACID,RO-may_treat
503223462,7/15/2014 11:18:50,,1323523234,7/15/2014 11:18:20,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223462,7/15/2014 11:52:44,,1323543128,7/15/2014 11:52:18,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,TUBERCULIN causes TUBERCULOSIS,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223462,7/15/2014 15:57:49,,1323647261,7/15/2014 15:57:19,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,TUBERCULIN causes TUBERCULOSIS,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223462,7/15/2014 16:58:25,,1323710183,7/15/2014 16:58:13,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,TUBERCULIN causes TUBERCULOSIS,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223462,7/15/2014 18:50:48,,1323782598,7/15/2014 18:50:46,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,TUBERCULIN causes TUBERCULOSIS,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223462,7/15/2014 20:37:46,,1323829575,7/15/2014 20:37:15,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223462,7/15/2014 22:16:05,,1323869312,7/15/2014 22:15:41,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,TUBERCULIN causes TUBERCULOSIS,137,84,,148,94,causes,0.674199862463242,906630-FS1-4,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223463,7/15/2014 11:23:25,,1323525755,7/15/2014 11:23:01,instagc,0.9417,13763729,USA,"","",75.182.89.225,DEFICIENCY OF SULFUR AMINO causes PROTEIN CALORIE MALNUTRITION,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 17:00:44,,1323712929,7/15/2014 17:00:29,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 17:23:41,,1323729124,7/15/2014 17:23:13,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 19:12:37,,1323794449,7/15/2014 19:11:51,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,DEFICIENCY OF SULFUR AMINO causes PROTEIN CALORIE MALNUTRITION,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 19:36:46,,1323805445,7/15/2014 19:36:23,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 22:16:35,,1323869566,7/15/2014 22:16:07,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,DEFICIENCY OF SULFUR AMINO causes PROTEIN CALORIE MALNUTRITION,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/16/2014 01:09:25,,1323962341,7/16/2014 01:09:04,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223464,7/15/2014 10:11:10,,1323477154,7/15/2014 10:10:41,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 10:30:12,,1323489260,7/15/2014 10:30:04,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 11:28:25,,1323528630,7/15/2014 11:28:02,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 11:52:44,,1323543131,7/15/2014 11:52:18,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 12:16:46,,1323552955,7/15/2014 12:16:14,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 17:16:03,,1323725235,7/15/2014 17:15:38,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 19:37:04,,1323805547,7/15/2014 19:36:47,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.972271824131503,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223465,7/15/2014 10:10:39,,1323476918,7/15/2014 10:10:16,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 11:23:38,,1323525869,7/15/2014 11:23:26,instagc,0.9417,13763729,USA,"","",75.182.89.225,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 14:33:28,,1323599324,7/15/2014 14:33:21,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,FEVER causes PHAEOCHROMOCYTOMA,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 15:24:48,,1323622776,7/15/2014 15:24:32,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,no_relation,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 15:56:50,,1323646493,7/15/2014 15:56:25,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 18:48:22,,1323781293,7/15/2014 18:47:49,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 19:06:36,,1323791226,7/15/2014 19:05:56,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223466,7/15/2014 10:27:30,,1323487444,7/15/2014 10:27:21,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,DYSPLASIA causes LESION (LSIL),181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223466,7/15/2014 10:31:19,,1323490077,7/15/2014 10:30:44,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223466,7/15/2014 11:17:45,,1323522501,7/15/2014 11:17:22,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223466,7/15/2014 11:23:06,,1323525593,7/15/2014 11:22:43,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223466,7/15/2014 11:26:43,,1323527545,7/15/2014 11:26:17,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223466,7/15/2014 13:58:30,,1323589246,7/15/2014 13:57:42,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,LESION (LSIL) causes DYSPLASIA,181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223466,7/15/2014 14:12:43,,1323593115,7/15/2014 14:12:23,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,181,35,,189,48,causes,0.549442255794756,901899-FS1-4,"Low grade squamous intraepithelial LESION (LSIL) (cellular changes consistent with HPV, mild dysplasia, CIN 1) High grade squamous intraepithelial lesion (HSIL) (moderate to severe DYSPLASIA CIN 2, CIN 3, CIS) (indicate if there are features suspicious of invasion) Squamous cell carcinoma Glandular cell Atypical glandular cells (specify endocervical, endometrial, or not otherwise specified) Atypical glandular cells, favor neoplastic (specify endocervi calor or not otherwise specified) Endocervical adenocarcinoma in situ (AIS) Adenocarcinoma Other (list not comprehensive.",DYSPLASIA,LESION (LSIL),RO-disease_has_finding
503223467,7/15/2014 11:23:06,,1323525592,7/15/2014 11:22:43,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,PIMECROLIMUS treats ATOPIC DERMATITIS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223467,7/15/2014 14:33:56,,1323599482,7/15/2014 14:33:50,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,PIMECROLIMUS treats ATOPIC DERMATITIS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223467,7/15/2014 16:53:53,,1323704963,7/15/2014 16:53:44,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,PIMECROLIMUS treats ATOPIC DERMATITIS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223467,7/15/2014 17:00:44,,1323712912,7/15/2014 17:00:29,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,PIMECROLIMUS treats ATOPIC DERMATITIS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223467,7/15/2014 17:58:45,,1323761185,7/15/2014 17:58:25,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,PIMECROLIMUS treats ATOPIC DERMATITIS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223467,7/15/2014 18:50:48,,1323782589,7/15/2014 18:50:46,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,ATOPIC DERMATITIS treats PIMECROLIMUS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223467,7/15/2014 19:41:17,,1323807398,7/15/2014 19:40:54,clixsense,0.6984,24429778,AUS,"","",121.211.19.218,PIMECROLIMUS treats ATOPIC DERMATITIS,96,0,,112,12,treats,1,908166-FS1-2,PIMECROLIMUS has generated recognition as a topical non steroidal drug labeled for treatment of ATOPIC DERMATITIS,ATOPIC DERMATITIS,PIMECROLIMUS,RO-may_treat
503223468,7/15/2014 10:33:58,,1323491769,7/15/2014 10:33:20,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 13:14:16,,1323574916,7/15/2014 13:13:26,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,BONE METASTASES is location of METASTATIC LESION OF THE SKULL,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 14:24:56,,1323596633,7/15/2014 14:24:11,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,METASTATIC LESION OF THE SKULL is location of BONE METASTASES,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 16:57:41,,1323709363,7/15/2014 16:57:23,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,BONE METASTASES is location of METASTATIC LESION OF THE SKULL,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 18:51:05,,1323782741,7/15/2014 18:51:02,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,METASTATIC LESION OF THE SKULL is location of BONE METASTASES,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 18:54:38,,1323784681,7/15/2014 18:54:34,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,METASTATIC LESION OF THE SKULL is location of BONE METASTASES,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 19:12:37,,1323794450,7/15/2014 19:11:51,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,BONE METASTASES is location of METASTATIC LESION OF THE SKULL,44,24,,73,39,is location of,0.424264068711929,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223469,7/15/2014 18:46:54,,1323780484,7/15/2014 18:46:23,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,VASOPRESSIN treats DIABETES INSIPIDUS,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223469,7/15/2014 22:16:54,,1323869690,7/15/2014 22:16:49,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,VASOPRESSIN treats DIABETES INSIPIDUS,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223469,7/15/2014 22:40:43,,1323881327,7/15/2014 22:40:28,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,VASOPRESSIN treats DIABETES INSIPIDUS,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223469,7/16/2014 00:44:40,,1323947889,7/16/2014 00:44:02,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223469,7/16/2014 02:17:20,,1323995969,7/16/2014 02:17:15,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,VASOPRESSIN treats DIABETES INSIPIDUS,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223469,7/16/2014 02:36:06,,1324003318,7/16/2014 02:35:38,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223469,7/16/2014 03:58:37,,1324034037,7/16/2014 03:57:54,clixsense,0.381,6330991,USA,NJ,Belvidere,69.141.104.97,DIABETES INSIPIDUS treats VASOPRESSIN,130,71,,147,82,treats,0.444444444444444,906588-FS1-2,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223470,7/15/2014 10:31:39,,1323490295,7/15/2014 10:31:20,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223470,7/15/2014 14:13:01,,1323593189,7/15/2014 14:12:44,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223470,7/15/2014 15:32:24,,1323628150,7/15/2014 15:32:07,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223470,7/15/2014 16:54:05,,1323705147,7/15/2014 16:53:54,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223470,7/15/2014 17:55:27,,1323758165,7/15/2014 17:55:13,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223470,7/15/2014 18:46:54,,1323780474,7/15/2014 18:46:23,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223470,7/15/2014 21:31:44,,1323852070,7/15/2014 21:31:23,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,STOMACH is location of EARLY GASTRIC CANCER,123,52,,129,72,is location of,0.953998092005724,905016-FS1-9,We studied the clinicopathological features of four EARLY GASTRIC CANCER patients with DSCs in the submucosal layer of the STOMACH,STOMACH,EARLY GASTRIC CANCER,RO-has_finding_site
503223471,7/15/2014 13:34:49,,1323581929,7/15/2014 13:34:27,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 14:33:28,,1323599323,7/15/2014 14:33:21,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,FALLOPIAN TUBE INFECTION is location of FALLOPIAN TUBES,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 15:48:52,,1323640414,7/15/2014 15:48:31,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,FALLOPIAN TUBE INFECTION is location of FALLOPIAN TUBES,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 15:54:49,,1323644966,7/15/2014 15:54:33,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 18:54:57,,1323784835,7/15/2014 18:54:53,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,no_relation,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 19:34:09,,1323804294,7/15/2014 19:33:56,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 20:37:46,,1323829576,7/15/2014 20:37:15,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223472,7/15/2014 10:52:54,,1323505035,7/15/2014 10:52:43,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,NEUROENDOCRINE DIFFERENTIATION causes CANCER (SCLC),52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223472,7/15/2014 11:18:18,,1323522885,7/15/2014 11:17:46,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,CANCER (SCLC) causes NEUROENDOCRINE DIFFERENTIATION,52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223472,7/15/2014 11:35:16,,1323532538,7/15/2014 11:34:47,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,CANCER (SCLC) causes NEUROENDOCRINE DIFFERENTIATION,52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223472,7/15/2014 13:07:57,,1323572723,7/15/2014 13:07:49,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,NEUROENDOCRINE DIFFERENTIATION causes CANCER (SCLC),52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223472,7/15/2014 15:18:11,,1323618478,7/15/2014 15:17:35,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223472,7/15/2014 15:24:31,,1323622564,7/15/2014 15:24:15,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,CANCER (SCLC) causes NEUROENDOCRINE DIFFERENTIATION,52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223472,7/15/2014 15:49:15,,1323640735,7/15/2014 15:48:54,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,CANCER (SCLC) causes NEUROENDOCRINE DIFFERENTIATION,52,16,,81,29,causes,0.99654575824488,901737-FS1-4,Small cell lung CANCER (SCLC) manifests a number of NEUROENDOCRINE DIFFERENTIATION features and antigenic characteristics that distinguish the tumour from non small cell lung cancer (NSCLC.,NEUROENDOCRINE DIFFERENTIATION,CANCER (SCLC),RO-disease_has_finding
503223473,7/15/2014 18:50:40,,1323782533,7/15/2014 18:50:32,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,PRIMARY MELANOMA is location of CUTANEOUS MELANOMA,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/15/2014 19:53:33,,1323811606,7/15/2014 19:52:47,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/15/2014 22:40:02,,1323881071,7/15/2014 22:39:46,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 02:17:48,,1323996238,7/16/2014 02:17:26,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,CUTANEOUS MELANOMA is location of PRIMARY MELANOMA,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 02:36:34,,1324003453,7/16/2014 02:36:07,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 03:59:13,,1324034325,7/16/2014 03:58:38,clixsense,0.381,6330991,USA,NJ,Belvidere,69.141.104.97,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 05:00:18,,1324057714,7/16/2014 04:59:41,instagc,0.5714,27770607,USA,TX,El Paso,72.183.248.75,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223474,7/15/2014 10:32:00,,1323490516,7/15/2014 10:31:40,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223474,7/15/2014 11:22:05,,1323525005,7/15/2014 11:21:46,instagc,0.9417,13763729,USA,"","",75.182.89.225,no_relation,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223474,7/15/2014 11:35:15,,1323532563,7/15/2014 11:34:54,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223474,7/15/2014 11:52:17,,1323542776,7/15/2014 11:51:58,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,THROMBOCYTOSIS causes PRIMARY THROMBOCYTHEMIA,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223474,7/15/2014 15:43:00,,1323636001,7/15/2014 15:42:43,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,PRIMARY THROMBOCYTHEMIA causes THROMBOCYTOSIS,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223474,7/15/2014 22:17:06,,1323869755,7/15/2014 22:16:55,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,PRIMARY THROMBOCYTHEMIA causes THROMBOCYTOSIS,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223474,7/16/2014 00:39:30,,1323945601,7/16/2014 00:38:30,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,PRIMARY THROMBOCYTHEMIA causes THROMBOCYTOSIS,200,122,,213,145,causes,0.341881729378914,906481-FS1-4,The results indicate that the 21q  marker chromosome may be due to a true deletion and that the marker is no specific for PRIMARY THROMBOCYTHEMIA or other myeloproliferative disorders associated with THROMBOCYTOSIS,THROMBOCYTOSIS,PRIMARY THROMBOCYTHEMIA,RO-has_manifestation
503223475,7/15/2014 11:34:46,,1323532259,7/15/2014 11:34:12,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 12:42:44,,1323562724,7/15/2014 12:42:23,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 13:35:38,,1323582202,7/15/2014 13:34:54,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 13:55:38,,1323588387,7/15/2014 13:55:15,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 14:14:38,,1323593581,7/15/2014 14:13:58,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 15:24:13,,1323622384,7/15/2014 15:23:49,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,no_relation,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 15:31:39,,1323627595,7/15/2014 15:31:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223476,7/15/2014 11:54:47,,1323544180,7/15/2014 11:54:35,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,NEUROFIBROMATOSIS causes NERVOUS SYSTEM,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223476,7/15/2014 12:56:21,,1323568136,7/15/2014 12:55:57,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223476,7/15/2014 13:57:00,,1323588861,7/15/2014 13:56:38,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,NERVOUS SYSTEM causes NEUROFIBROMATOSIS,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223476,7/15/2014 14:13:45,,1323593361,7/15/2014 14:13:12,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223476,7/15/2014 19:36:22,,1323805296,7/15/2014 19:36:07,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,no_relation,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223476,7/16/2014 01:09:44,,1323962524,7/16/2014 01:09:25,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,no_relation,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223476,7/16/2014 02:17:09,,1323995865,7/16/2014 02:16:54,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,NERVOUS SYSTEM causes NEUROFIBROMATOSIS,108,0,,121,17,causes,0.629940788348712,905210-FS1-4,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223477,7/15/2014 10:31:00,,1323489828,7/15/2014 10:30:32,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:01:17,,1323510229,7/15/2014 11:00:49,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:28:00,,1323528314,7/15/2014 11:27:41,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:33:53,,1323531732,7/15/2014 11:33:29,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,ARTHRITIS is location of THE BASAL JOINT OF THE THUMB,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:34:46,,1323532258,7/15/2014 11:34:12,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 12:41:15,,1323562163,7/15/2014 12:40:55,instagc,0.7417,18960682,GBR,"","",86.29.147.112,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 15:19:45,,1323619367,7/15/2014 15:19:16,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223478,7/15/2014 11:33:14,,1323531277,7/15/2014 11:32:25,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 11:34:52,,1323532317,7/15/2014 11:34:20,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,PREGNANCY COMPLICATION causes PREECLAMPSIA,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 12:15:27,,1323552513,7/15/2014 12:14:59,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 13:07:46,,1323572695,7/15/2014 13:07:36,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,PREGNANCY COMPLICATION causes PREECLAMPSIA,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 13:33:50,,1323581663,7/15/2014 13:33:36,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 16:47:06,,1323697768,7/15/2014 16:46:58,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 19:52:04,,1323811125,7/15/2014 19:51:26,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223479,7/15/2014 10:57:31,,1323507901,7/15/2014 10:56:50,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:24:31,,1323622565,7/15/2014 15:24:15,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:32:52,,1323628519,7/15/2014 15:32:42,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:48:30,,1323640127,7/15/2014 15:48:03,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:53:39,,1323644027,7/15/2014 15:53:22,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 17:09:13,,1323720854,7/15/2014 17:08:33,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 18:54:32,,1323784625,7/15/2014 18:54:16,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223480,7/15/2014 10:28:30,,1323488252,7/15/2014 10:27:39,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223480,7/15/2014 10:55:27,,1323506767,7/15/2014 10:54:36,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223480,7/15/2014 11:24:30,,1323526427,7/15/2014 11:24:14,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223480,7/15/2014 11:51:06,,1323541788,7/15/2014 11:50:40,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223480,7/15/2014 14:13:45,,1323593360,7/15/2014 14:13:12,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223480,7/15/2014 14:22:48,,1323596010,7/15/2014 14:22:22,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223480,7/15/2014 16:58:02,,1323709709,7/15/2014 16:57:41,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,RABIES VIRUS causes RABIES,286,103,,297,109,causes,0.927172649945531,903925-FS1-4,"To improve both safety and stability of the oral vaccines used in the field to vaccinate foxes against RABIES a recombinant vaccinia virus, which expresses the immunizing G protein of rabies virus has been developed by inserting the cDNA which codes for the immunogenic glycoprotein of RABIES VIRUS into the thymidine kinase (TK) gene of the Copenhagen strain of vaccinia virus.",RABIES VIRUS,RABIES,RO-has_causative_agent
503223481,7/15/2014 19:11:49,,1323794049,7/15/2014 19:11:19,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223481,7/15/2014 21:30:31,,1323851604,7/15/2014 21:29:58,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223481,7/15/2014 22:16:48,,1323869646,7/15/2014 22:16:36,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223481,7/16/2014 00:46:49,,1323948931,7/16/2014 00:46:21,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223481,7/16/2014 01:44:34,,1323979955,7/16/2014 01:44:08,clixsense,0.7798,19638651,USA,"","",173.23.121.63,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223481,7/16/2014 02:17:25,,1323996001,7/16/2014 02:17:21,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223481,7/16/2014 02:35:37,,1324003163,7/16/2014 02:35:24,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.995893206467704,903537-FS1-2,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
503223482,7/15/2014 10:10:11,,1323476668,7/15/2014 10:10:03,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223482,7/15/2014 10:30:31,,1323489464,7/15/2014 10:30:06,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223482,7/15/2014 11:17:42,,1323522489,7/15/2014 11:17:12,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223482,7/15/2014 11:23:00,,1323525540,7/15/2014 11:22:34,instagc,0.9417,13763729,USA,"","",75.182.89.225,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223482,7/15/2014 11:33:53,,1323531754,7/15/2014 11:33:29,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223482,7/15/2014 11:51:57,,1323542457,7/15/2014 11:51:41,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223482,7/15/2014 15:49:33,,1323640910,7/15/2014 15:49:17,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.991836598134176,908164-FS1-2,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
503223483,7/15/2014 10:30:30,,1323489473,7/15/2014 10:30:21,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,ISLET CELLS is location of DIABETES,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223483,7/15/2014 10:30:56,,1323489770,7/15/2014 10:30:33,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,ISLET CELLS is location of DIABETES,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223483,7/15/2014 11:24:50,,1323526606,7/15/2014 11:24:31,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223483,7/15/2014 11:51:40,,1323542255,7/15/2014 11:51:24,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,ISLET CELLS is location of DIABETES,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223483,7/15/2014 11:55:02,,1323544279,7/15/2014 11:54:48,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,ISLET CELLS is location of DIABETES,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223483,7/15/2014 13:54:15,,1323587978,7/15/2014 13:53:21,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,ISLET CELLS is location of DIABETES,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223483,7/15/2014 13:54:25,,1323588022,7/15/2014 13:53:25,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,100,155,,110,163,is location of,0.308606699924184,902036-FS1-9,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223484,7/15/2014 10:52:54,,1323505056,7/15/2014 10:52:43,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,FETAL FLUORIDE treats CARIES,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 11:22:41,,1323525292,7/15/2014 11:22:01,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,FETAL FLUORIDE treats CARIES,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 11:34:18,,1323532012,7/15/2014 11:33:54,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 17:58:41,,1323761155,7/15/2014 17:58:22,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,CARIES treats FETAL FLUORIDE,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 19:54:52,,1323812038,7/15/2014 19:54:17,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 20:24:38,,1323824119,7/15/2014 20:23:41,clixsense,0.5208,25399403,GBR,"","",188.29.96.57,no_relation,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/16/2014 02:17:14,,1323995900,7/16/2014 02:17:09,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,FETAL FLUORIDE treats CARIES,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223485,7/15/2014 10:10:32,,1323476844,7/15/2014 10:10:13,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 11:35:41,,1323532763,7/15/2014 11:35:17,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,HYPERTENSION diagnosed by PHEOCHROMOCYTOMA,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 12:16:13,,1323552767,7/15/2014 12:15:28,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,HYPERTENSION diagnosed by PHEOCHROMOCYTOMA,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 13:15:51,,1323575486,7/15/2014 13:15:10,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 13:56:04,,1323588496,7/15/2014 13:55:43,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 16:52:15,,1323703330,7/15/2014 16:51:45,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 18:47:47,,1323780941,7/15/2014 18:46:55,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.674199862463242,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223486,7/15/2014 10:12:11,,1323477725,7/15/2014 10:11:40,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,DIABETES INSIPIDUS diagnosed by VASOPRESSIN,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223486,7/15/2014 11:10:48,,1323517894,7/15/2014 11:10:23,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,DIABETES INSIPIDUS diagnosed by VASOPRESSIN,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223486,7/15/2014 12:17:30,,1323553241,7/15/2014 12:16:47,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,VASOPRESSIN diagnosed by DIABETES INSIPIDUS,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223486,7/15/2014 19:05:55,,1323790921,7/15/2014 19:05:04,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,DIABETES INSIPIDUS diagnosed by VASOPRESSIN,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223486,7/16/2014 00:40:32,,1323946080,7/16/2014 00:39:30,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,DIABETES INSIPIDUS diagnosed by VASOPRESSIN,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223486,7/16/2014 01:08:23,,1323961670,7/16/2014 01:07:59,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,DIABETES INSIPIDUS diagnosed by VASOPRESSIN,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223486,7/16/2014 02:17:20,,1323995968,7/16/2014 02:17:15,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,no_relation,130,71,,147,82,diagnosed by,0.888888888888889,906588-FS1-13,Results of restriction of liquids followed by intravenous injection of VASOPRESSIN (Miller test) favoured a diagnosis of complete DIABETES INSIPIDUS,DIABETES INSIPIDUS,VASOPRESSIN,RO-may_diagnose
503223487,7/15/2014 11:33:03,,1323531188,7/15/2014 11:32:36,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223487,7/15/2014 11:33:40,,1323531610,7/15/2014 11:33:14,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223487,7/15/2014 13:57:40,,1323589009,7/15/2014 13:56:46,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223487,7/15/2014 15:19:45,,1323619363,7/15/2014 15:19:16,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223487,7/15/2014 15:49:33,,1323640905,7/15/2014 15:49:17,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,REFLUX TO THE STOMACH treats PATHOGENESIS OF RESIDUAL GASTRITIS,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223487,7/15/2014 17:57:30,,1323760304,7/15/2014 17:57:14,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,PATHOGENESIS OF RESIDUAL GASTRITIS treats REFLUX TO THE STOMACH,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223487,7/15/2014 20:35:32,,1323828646,7/15/2014 20:34:36,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,REFLUX TO THE STOMACH treats PATHOGENESIS OF RESIDUAL GASTRITIS,5,63,,25,97,treats,0.493196961916072,902170-FS1-2,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223488,7/15/2014 16:49:58,,1323700860,7/15/2014 16:49:25,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/15/2014 17:00:57,,1323713201,7/15/2014 17:00:45,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/15/2014 19:41:42,,1323807566,7/15/2014 19:41:19,clixsense,0.6984,24429778,AUS,"","",121.211.19.218,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/15/2014 19:52:47,,1323811335,7/15/2014 19:52:04,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/16/2014 01:09:25,,1323962342,7/16/2014 01:09:04,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/16/2014 01:44:06,,1323979743,7/16/2014 01:43:46,clixsense,0.7798,19638651,USA,"","",173.23.121.63,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/16/2014 02:17:48,,1323996239,7/16/2014 02:17:26,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223489,7/15/2014 11:21:59,,1323524993,7/15/2014 11:21:38,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223489,7/15/2014 14:33:35,,1323599381,7/15/2014 14:33:30,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,LOCAL PAIN causes NEURALGIA SYNDROME,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223489,7/15/2014 15:55:10,,1323645263,7/15/2014 15:54:50,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223489,7/15/2014 15:55:48,,1323645711,7/15/2014 15:55:19,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223489,7/15/2014 16:53:06,,1323704140,7/15/2014 16:52:23,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,NEURALGIA SYNDROME causes LOCAL PAIN,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223489,7/15/2014 17:00:05,,1323712287,7/15/2014 16:59:50,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223489,7/15/2014 18:50:40,,1323782532,7/15/2014 18:50:32,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,28,54,,37,72,causes,0.468521285665818,904590-FS1-4,"The principal symptoms were LOCAL PAIN in 8 patients, NEURALGIA SYNDROME in 3, and rupture in 2.",LOCAL PAIN,NEURALGIA SYNDROME,RO-has_definitional_manifestation
503223490,7/15/2014 10:32:36,,1323490895,7/15/2014 10:32:04,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,KIDNEYS is location of PYELONEPHRITIS,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223490,7/15/2014 11:18:45,,1323523155,7/15/2014 11:18:34,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,KIDNEYS is location of PYELONEPHRITIS,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223490,7/15/2014 12:40:54,,1323562028,7/15/2014 12:40:44,instagc,0.7417,18960682,GBR,"","",86.29.147.112,KIDNEYS is location of PYELONEPHRITIS,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223490,7/15/2014 14:21:49,,1323595768,7/15/2014 14:21:23,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,KIDNEYS is location of PYELONEPHRITIS,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223490,7/15/2014 22:40:17,,1323881185,7/15/2014 22:40:11,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223490,7/16/2014 00:37:34,,1323944690,7/16/2014 00:36:32,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,PYELONEPHRITIS is location of KIDNEYS,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223490,7/16/2014 01:45:19,,1323980151,7/16/2014 01:45:00,clixsense,0.7798,19638651,USA,"","",173.23.121.63,KIDNEYS is location of PYELONEPHRITIS,105,64,,111,78,is location of,0.923760430703401,905268-FS1-9,"In the pathogenesis of glomerulonephritis, acute renal failure, PYELONEPHRITIS and other diseases of the KIDNEYS oxygen radicals are involved.",KIDNEYS,PYELONEPHRITIS,RO-has_finding_site
503223491,7/15/2014 10:52:21,,1323504724,7/15/2014 10:52:13,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,HAEMOPHAGOCYTOSIS causes HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 11:33:27,,1323531431,7/15/2014 11:33:04,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 11:51:23,,1323542058,7/15/2014 11:51:07,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 12:16:13,,1323552765,7/15/2014 12:15:28,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 13:54:25,,1323588015,7/15/2014 13:53:25,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 16:47:27,,1323698055,7/15/2014 16:47:19,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,HAEMOPHAGOCYTOSIS causes HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 17:56:16,,1323759061,7/15/2014 17:55:53,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.447213595499958,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223492,7/15/2014 12:42:44,,1323562725,7/15/2014 12:42:23,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223492,7/15/2014 12:54:37,,1323567498,7/15/2014 12:54:12,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,EFFECT ON THE VOMITING CENTER OF THE causes NAUSEA AND VOMITING,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223492,7/15/2014 17:14:08,,1323724279,7/15/2014 17:13:06,clixsense,0.381,8288298,USA,WA,Seattle,97.113.15.58,NAUSEA AND VOMITING causes EFFECT ON THE VOMITING CENTER OF THE,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223492,7/15/2014 18:51:05,,1323782740,7/15/2014 18:51:02,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223492,7/15/2014 19:22:07,,1323799085,7/15/2014 19:21:32,clixsense,0.4583,11338264,CAN,ON,Aurora,184.148.114.225,EFFECT ON THE VOMITING CENTER OF THE causes NAUSEA AND VOMITING,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223492,7/15/2014 19:41:42,,1323807567,7/15/2014 19:41:19,clixsense,0.6984,24429778,AUS,"","",121.211.19.218,EFFECT ON THE VOMITING CENTER OF THE causes NAUSEA AND VOMITING,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223492,7/16/2014 01:09:03,,1323962095,7/16/2014 01:08:42,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,EFFECT ON THE VOMITING CENTER OF THE causes NAUSEA AND VOMITING,83,41,,118,60,causes,0.990147542976674,904633-FS1-4,The most common immediate side effect is NAUSEA AND VOMITING due to direct central EFFECT ON THE VOMITING CENTER OF THE brain.,EFFECT ON THE VOMITING CENTER OF THE,NAUSEA AND VOMITING,RO-has_definitional_manifestation
503223493,7/15/2014 10:30:31,,1323489471,7/15/2014 10:30:06,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,IPSID causes ABDOMINAL PAIN,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223493,7/15/2014 11:54:47,,1323544182,7/15/2014 11:54:35,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,IPSID causes ABDOMINAL PAIN,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223493,7/15/2014 14:22:12,,1323595836,7/15/2014 14:21:50,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223493,7/15/2014 16:51:44,,1323702697,7/15/2014 16:50:52,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,no_relation,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223493,7/15/2014 16:57:23,,1323708997,7/15/2014 16:56:53,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,ABDOMINAL PAIN causes IPSID,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223493,7/15/2014 17:58:23,,1323761003,7/15/2014 17:58:07,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,IPSID causes ABDOMINAL PAIN,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223493,7/15/2014 22:40:02,,1323881075,7/15/2014 22:39:46,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,50,36,,63,41,causes,0.959403223600247,902542-FS1-4,"Among the lymphoma patients without IPSID 65% had ABDOMINAL PAIN weight loss, abdominal masses, obstruction, and perforation.",ABDOMINAL PAIN,IPSID,RO-disease_may_have_finding
503223494,7/15/2014 10:10:11,,1323476666,7/15/2014 10:10:03,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,no_relation,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223494,7/15/2014 11:21:46,,1323524861,7/15/2014 11:21:23,instagc,0.9417,13763729,USA,"","",75.182.89.225,no_relation,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223494,7/15/2014 11:34:11,,1323531922,7/15/2014 11:33:42,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223494,7/15/2014 12:39:22,,1323561572,7/15/2014 12:38:58,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,CENTRAL NEUROFIBROMATOSIS causes INVASIVE MENINGIOMA,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223494,7/15/2014 17:57:13,,1323760042,7/15/2014 17:56:57,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,INVASIVE MENINGIOMA causes CENTRAL NEUROFIBROMATOSIS,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223494,7/15/2014 19:22:07,,1323799083,7/15/2014 19:21:32,clixsense,0.4583,11338264,CAN,ON,Aurora,184.148.114.225,INVASIVE MENINGIOMA causes CENTRAL NEUROFIBROMATOSIS,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223494,7/15/2014 22:15:40,,1323869090,7/15/2014 22:15:25,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,CENTRAL NEUROFIBROMATOSIS causes INVASIVE MENINGIOMA,79,181,,97,206,causes,0.452267016866645,906180-FS1-4,"There were eight cases of meningiomas with aggressive characteristics, such as INVASIVE MENINGIOMA malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with CENTRAL NEUROFIBROMATOSIS",INVASIVE MENINGIOMA,CENTRAL NEUROFIBROMATOSIS,RO-has_manifestation
503223495,7/15/2014 11:25:05,,1323526739,7/15/2014 11:24:52,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223495,7/15/2014 14:15:18,,1323593721,7/15/2014 14:14:49,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223495,7/15/2014 15:45:19,,1323637898,7/15/2014 15:44:49,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,DRUG NAIVE ANIMALS causes ACUTE TOLERANCE,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223495,7/15/2014 16:57:41,,1323709384,7/15/2014 16:57:23,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,DRUG NAIVE ANIMALS causes ACUTE TOLERANCE,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223495,7/15/2014 18:51:00,,1323782697,7/15/2014 18:50:55,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223495,7/15/2014 20:24:38,,1323824120,7/15/2014 20:23:41,clixsense,0.5208,25399403,GBR,"","",188.29.96.57,no_relation,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223495,7/16/2014 00:41:18,,1323946415,7/16/2014 00:40:33,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,ACUTE TOLERANCE causes DRUG NAIVE ANIMALS,109,40,,126,55,causes,0.609994281330419,903964-FS1-4,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223496,7/15/2014 10:12:40,,1323477965,7/15/2014 10:12:20,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,ANTHRAX causes BACILLUS ANTHRACIS,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223496,7/15/2014 19:37:26,,1323805692,7/15/2014 19:37:06,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,no_relation,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223496,7/15/2014 22:41:44,,1323881731,7/15/2014 22:41:32,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,BACILLUS ANTHRACIS causes ANTHRAX,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223496,7/16/2014 00:36:31,,1323944234,7/16/2014 00:35:36,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,BACILLUS ANTHRACIS causes ANTHRAX,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223496,7/16/2014 00:45:44,,1323948427,7/16/2014 00:45:15,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,BACILLUS ANTHRACIS causes ANTHRAX,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223496,7/16/2014 01:44:53,,1323980049,7/16/2014 01:44:34,clixsense,0.7798,19638651,USA,"","",173.23.121.63,BACILLUS ANTHRACIS causes ANTHRAX,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223496,7/16/2014 02:36:46,,1324003501,7/16/2014 02:36:36,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,BACILLUS ANTHRACIS causes ANTHRAX,0,45,,17,52,causes,1,903605-FS1-4,BACILLUS ANTHRACIS is the causative agent of ANTHRAX and the spore form of the bacterium represents the infectious particle introduced into a host.,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
503223497,7/15/2014 10:11:10,,1323477161,7/15/2014 10:10:41,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 11:10:22,,1323517528,7/15/2014 11:10:03,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 11:40:19,,1323535424,7/15/2014 11:39:53,clixsense,0.5,23233834,GBR,N6,Sunderland,86.17.58.181,HYPERTENSION causes PHEOCHROMOCYTOMA,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 13:55:38,,1323588392,7/15/2014 13:55:15,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 15:32:05,,1323627917,7/15/2014 15:31:58,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 19:42:04,,1323807727,7/15/2014 19:41:44,clixsense,0.6984,24429778,AUS,"","",121.211.19.218,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 21:31:44,,1323852052,7/15/2014 21:31:23,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.539359889970594,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223498,7/15/2014 10:30:03,,1323489167,7/15/2014 10:29:55,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223498,7/15/2014 11:27:06,,1323527790,7/15/2014 11:26:45,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,COMPLICATIONS OF PREGNANCY causes PREECLAMPSIA,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223498,7/15/2014 13:57:00,,1323588865,7/15/2014 13:56:38,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223498,7/15/2014 16:58:12,,1323709919,7/15/2014 16:58:03,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223498,7/15/2014 17:09:41,,1323721166,7/15/2014 17:09:16,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,COMPLICATIONS OF PREGNANCY causes PREECLAMPSIA,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223498,7/15/2014 20:37:13,,1323829341,7/15/2014 20:36:36,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,COMPLICATIONS OF PREGNANCY causes PREECLAMPSIA,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223498,7/15/2014 22:16:54,,1323869691,7/15/2014 22:16:49,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,41,0,,66,12,causes,0.953462589245592,901807-FS1-4,"PREECLAMPSIA is one of the most frequent COMPLICATIONS OF PREGNANCY however, little is known about its etiology.",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503223499,7/15/2014 10:27:33,,1323487481,7/15/2014 10:26:57,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,CALCITONIN treats HYPERCALCEMIA OF MALIGNANCY,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223499,7/15/2014 10:52:21,,1323504751,7/15/2014 10:52:13,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,CALCITONIN treats HYPERCALCEMIA OF MALIGNANCY,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223499,7/15/2014 13:55:10,,1323588218,7/15/2014 13:54:44,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,HYPERCALCEMIA OF MALIGNANCY treats CALCITONIN,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223499,7/15/2014 19:13:34,,1323794930,7/15/2014 19:13:03,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,CALCITONIN treats HYPERCALCEMIA OF MALIGNANCY,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223499,7/15/2014 21:31:22,,1323851913,7/15/2014 21:30:32,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,CALCITONIN treats HYPERCALCEMIA OF MALIGNANCY,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223499,7/16/2014 01:08:41,,1323961864,7/16/2014 01:08:24,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,CALCITONIN treats HYPERCALCEMIA OF MALIGNANCY,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223499,7/16/2014 01:44:53,,1323980045,7/16/2014 01:44:34,clixsense,0.7798,19638651,USA,"","",173.23.121.63,CALCITONIN treats HYPERCALCEMIA OF MALIGNANCY,50,98,,76,108,treats,0.987829161147262,907491-FS1-2,"Other agents used in the second line treatment of HYPERCALCEMIA OF MALIGNANCY include plicamycin, CALCITONIN gallium nitrate, and the glucocorticoids.",HYPERCALCEMIA OF MALIGNANCY,CALCITONIN,RO-may_treat
503223500,7/15/2014 10:52:31,,1323504814,7/15/2014 10:52:23,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,BRAIN causes MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223500,7/15/2014 12:14:24,,1323552088,7/15/2014 12:14:02,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,BRAIN causes MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223500,7/15/2014 12:40:32,,1323561897,7/15/2014 12:40:21,instagc,0.7417,18960682,GBR,"","",86.29.147.112,no_relation,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223500,7/15/2014 14:13:01,,1323593190,7/15/2014 14:12:44,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223500,7/15/2014 15:25:17,,1323623035,7/15/2014 15:24:49,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,no_relation,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223500,7/15/2014 16:25:23,,1323671773,7/15/2014 16:25:11,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223500,7/15/2014 16:52:33,,1323703648,7/15/2014 16:52:16,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,no_relation,33,62,,37,92,causes,0.314485451016576,902284-FS1-4,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223501,7/15/2014 11:28:00,,1323528332,7/15/2014 11:27:41,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223501,7/15/2014 11:55:18,,1323544412,7/15/2014 11:55:05,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,PREECLAMPSIA causes COMPLICATED PREGNANCIES,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223501,7/15/2014 12:43:29,,1323562988,7/15/2014 12:43:09,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223501,7/15/2014 13:54:15,,1323587972,7/15/2014 13:53:21,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PREECLAMPSIA causes COMPLICATED PREGNANCIES,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223501,7/15/2014 14:33:49,,1323599434,7/15/2014 14:33:43,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,PREECLAMPSIA causes COMPLICATED PREGNANCIES,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223501,7/15/2014 16:51:44,,1323702700,7/15/2014 16:50:52,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,no_relation,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223501,7/15/2014 18:54:42,,1323784724,7/15/2014 18:54:39,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,COMPLICATED PREGNANCIES causes PREECLAMPSIA,42,146,,64,158,causes,0.949425326555083,901933-FS1-4,The differences between uncomplicated and COMPLICATED PREGNANCIES offer new endpoints for an early identification of gestational hypertension and PREECLAMPSIA,COMPLICATED PREGNANCIES,PREECLAMPSIA,RO-disease_has_finding
503223502,7/15/2014 10:29:54,,1323489082,7/15/2014 10:29:41,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223502,7/15/2014 10:52:31,,1323504820,7/15/2014 10:52:23,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223502,7/15/2014 11:20:36,,1323524250,7/15/2014 11:20:10,clixsense,0.1667,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223502,7/15/2014 11:51:23,,1323542057,7/15/2014 11:51:07,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223502,7/15/2014 11:54:15,,1323543976,7/15/2014 11:54:05,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223502,7/15/2014 12:17:30,,1323553242,7/15/2014 12:16:47,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223502,7/15/2014 15:18:46,,1323618750,7/15/2014 15:18:12,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439-FS1-2,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223503,7/15/2014 11:25:05,,1323526743,7/15/2014 11:24:52,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 11:27:40,,1323528160,7/15/2014 11:27:27,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 11:33:40,,1323531609,7/15/2014 11:33:14,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 12:43:07,,1323562858,7/15/2014 12:42:45,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 13:07:46,,1323572696,7/15/2014 13:07:36,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,no_relation,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 13:35:58,,1323582387,7/15/2014 13:35:45,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 15:31:57,,1323627810,7/15/2014 15:31:41,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223504,7/15/2014 14:24:03,,1323596450,7/15/2014 14:23:21,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,DEXTROSE contraindicates HYPOGLYCEMIA,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 15:24:48,,1323622783,7/15/2014 15:24:32,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,DEXTROSE contraindicates HYPOGLYCEMIA,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 15:44:18,,1323637081,7/15/2014 15:43:57,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,no_relation,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 17:00:27,,1323712657,7/15/2014 17:00:07,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 17:58:06,,1323760755,7/15/2014 17:57:51,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,HYPOGLYCEMIA contraindicates DEXTROSE,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 17:58:54,,1323761261,7/15/2014 17:58:43,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,HYPOGLYCEMIA contraindicates DEXTROSE,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 18:54:42,,1323784729,7/15/2014 18:54:39,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,no_relation,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223505,7/15/2014 11:23:38,,1323525871,7/15/2014 11:23:26,instagc,0.9417,13763729,USA,"","",75.182.89.225,EPSTEIN BARR VIRUS causes INFECTIOUS MONONUCLEOSIS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223505,7/15/2014 14:15:38,,1323593877,7/15/2014 14:15:21,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,EPSTEIN BARR VIRUS causes INFECTIOUS MONONUCLEOSIS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223505,7/15/2014 14:33:56,,1323599481,7/15/2014 14:33:50,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,EPSTEIN BARR VIRUS causes INFECTIOUS MONONUCLEOSIS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223505,7/15/2014 15:18:46,,1323618747,7/15/2014 15:18:12,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,EPSTEIN BARR VIRUS causes INFECTIOUS MONONUCLEOSIS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223505,7/15/2014 16:46:49,,1323697360,7/15/2014 16:46:42,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,INFECTIOUS MONONUCLEOSIS causes EPSTEIN BARR VIRUS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223505,7/15/2014 17:24:18,,1323729404,7/15/2014 17:23:47,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,EPSTEIN BARR VIRUS causes INFECTIOUS MONONUCLEOSIS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223505,7/15/2014 19:52:04,,1323811124,7/15/2014 19:51:26,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,EPSTEIN BARR VIRUS causes INFECTIOUS MONONUCLEOSIS,0,48,,17,72,causes,0.99654575824488,903553-FS1-4,EPSTEIN BARR VIRUS is a herpesvirus that causes INFECTIOUS MONONUCLEOSIS carcinomas and immunoproliferative disease.,EPSTEIN BARR VIRUS,INFECTIOUS MONONUCLEOSIS,RO-has_causative_agent
503223506,7/15/2014 12:56:37,,1323568266,7/15/2014 12:56:22,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223506,7/15/2014 15:32:52,,1323628527,7/15/2014 15:32:42,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223506,7/15/2014 15:48:52,,1323640413,7/15/2014 15:48:31,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223506,7/15/2014 15:55:33,,1323645523,7/15/2014 15:55:11,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223506,7/15/2014 19:13:02,,1323794631,7/15/2014 19:12:39,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223506,7/15/2014 19:55:32,,1323812297,7/15/2014 19:54:52,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223506,7/15/2014 22:40:27,,1323881236,7/15/2014 22:40:18,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,15,91,,31,122,treats,0.976092160357725,902403-FS1-2,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
503223507,7/15/2014 10:30:20,,1323489340,7/15/2014 10:30:13,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,HEADACHE TREATMENTS treats MIGRAINE DIAGNOSIS,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223507,7/15/2014 11:28:25,,1323528623,7/15/2014 11:28:02,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223507,7/15/2014 12:14:57,,1323552353,7/15/2014 12:14:26,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,MIGRAINE DIAGNOSIS treats HEADACHE TREATMENTS,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223507,7/15/2014 13:36:14,,1323582460,7/15/2014 13:36:01,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,HEADACHE TREATMENTS treats MIGRAINE DIAGNOSIS,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223507,7/15/2014 13:55:30,,1323588319,7/15/2014 13:54:33,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223507,7/15/2014 15:48:02,,1323639854,7/15/2014 15:47:41,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,MIGRAINE DIAGNOSIS treats HEADACHE TREATMENTS,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223507,7/15/2014 17:14:08,,1323724285,7/15/2014 17:13:06,clixsense,0.381,8288298,USA,WA,Seattle,97.113.15.58,MIGRAINE DIAGNOSIS treats HEADACHE TREATMENTS,105,73,,123,91,treats,0.707106781186547,904719-FS1-2,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223508,7/15/2014 11:11:53,,1323518705,7/15/2014 11:11:22,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 11:17:59,,1323522664,7/15/2014 11:17:43,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 11:52:17,,1323542778,7/15/2014 11:51:58,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 12:39:40,,1323561662,7/15/2014 12:39:23,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 13:03:42,,1323571227,7/15/2014 13:03:06,prodege,0.875,19192508,USA,OK,Broken Arrow,70.177.111.89,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 15:43:29,,1323636355,7/15/2014 15:43:01,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 15:57:18,,1323646848,7/15/2014 15:56:51,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.987829161147262,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223509,7/15/2014 10:55:27,,1323506768,7/15/2014 10:54:36,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,DEXTROSE causes HYPOGLYCEMIA,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223509,7/15/2014 11:10:48,,1323517897,7/15/2014 11:10:23,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223509,7/15/2014 15:57:49,,1323647264,7/15/2014 15:57:19,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223509,7/15/2014 16:24:25,,1323670624,7/15/2014 16:24:15,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223509,7/15/2014 17:01:33,,1323713728,7/15/2014 17:01:19,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223509,7/15/2014 17:57:49,,1323760647,7/15/2014 17:57:32,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,DEXTROSE causes HYPOGLYCEMIA,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223509,7/15/2014 18:54:47,,1323784749,7/15/2014 18:54:44,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,DEXTROSE causes HYPOGLYCEMIA,67,25,,78,33,causes,0.375,907545-FS1-4,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223510,7/15/2014 11:17:20,,1323522236,7/15/2014 11:16:44,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223510,7/15/2014 11:25:22,,1323526825,7/15/2014 11:25:06,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223510,7/15/2014 13:14:16,,1323574919,7/15/2014 13:13:26,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,no_relation,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223510,7/15/2014 13:34:24,,1323581837,7/15/2014 13:34:06,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,INTESTINAL TYPE ADENOCARCINOMA is location of INTESTINAL METAPLASIA,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223510,7/15/2014 15:16:40,,1323617694,7/15/2014 15:15:58,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223510,7/15/2014 15:48:02,,1323639853,7/15/2014 15:47:41,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,INTESTINAL METAPLASIA is location of INTESTINAL TYPE ADENOCARCINOMA,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223510,7/15/2014 16:52:22,,1323703470,7/15/2014 16:51:57,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,111,137,,131,167,is location of,0.371390676354104,901591-FS1-9,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223511,7/15/2014 11:16:09,,1323521346,7/15/2014 11:15:30,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 13:15:51,,1323575487,7/15/2014 13:15:10,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 17:09:13,,1323720842,7/15/2014 17:08:33,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 19:36:22,,1323805293,7/15/2014 19:36:07,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 19:53:33,,1323811605,7/15/2014 19:52:47,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/16/2014 01:43:44,,1323979654,7/16/2014 01:43:18,clixsense,0.7798,19638651,USA,"","",173.23.121.63,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/16/2014 02:17:14,,1323995908,7/16/2014 02:17:09,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223512,7/15/2014 10:12:19,,1323477811,7/15/2014 10:11:31,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 11:12:19,,1323519027,7/15/2014 11:11:54,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 11:20:36,,1323524249,7/15/2014 11:20:10,clixsense,0.1667,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 11:33:14,,1323531278,7/15/2014 11:32:25,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 13:54:35,,1323588093,7/15/2014 13:54:16,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,APNOEA treats CAFFEINE,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 13:57:40,,1323589010,7/15/2014 13:56:46,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 15:55:10,,1323645262,7/15/2014 15:54:50,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.957826285221151,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223513,7/15/2014 10:12:47,,1323478039,7/15/2014 10:12:12,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,IRON causes HEMOCHROMATOSIS,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223513,7/15/2014 11:10:22,,1323517555,7/15/2014 11:10:03,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223513,7/15/2014 11:19:15,,1323523551,7/15/2014 11:18:46,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223513,7/15/2014 12:54:37,,1323567497,7/15/2014 12:54:12,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,IRON causes HEMOCHROMATOSIS,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223513,7/15/2014 13:35:38,,1323582172,7/15/2014 13:34:54,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,HEMOCHROMATOSIS causes IRON,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223513,7/15/2014 16:50:50,,1323701793,7/15/2014 16:49:59,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,no_relation,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223513,7/15/2014 17:58:21,,1323760976,7/15/2014 17:58:13,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,IRON causes HEMOCHROMATOSIS,51,94,,65,98,causes,0.697485832462916,901227-FS1-4,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223514,7/15/2014 10:32:36,,1323490894,7/15/2014 10:32:04,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/15/2014 10:54:34,,1323506183,7/15/2014 10:54:08,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,METASTATIC LESIONS causes LIVER METASTASIS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/15/2014 17:10:07,,1323721492,7/15/2014 17:09:42,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/15/2014 20:33:55,,1323828043,7/15/2014 20:32:44,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/16/2014 00:40:32,,1323946073,7/16/2014 00:39:30,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,METASTATIC LESIONS causes LIVER METASTASIS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/16/2014 01:10:17,,1323962870,7/16/2014 01:09:45,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/16/2014 01:43:44,,1323979655,7/16/2014 01:43:18,clixsense,0.7798,19638651,USA,"","",173.23.121.63,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223515,7/15/2014 11:54:15,,1323543968,7/15/2014 11:54:05,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,WART VIRUS causes VERRUCA VULGARIS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223515,7/15/2014 12:40:54,,1323562024,7/15/2014 12:40:44,instagc,0.7417,18960682,GBR,"","",86.29.147.112,WART VIRUS causes VERRUCA VULGARIS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223515,7/15/2014 15:43:29,,1323636333,7/15/2014 15:43:01,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,WART VIRUS causes VERRUCA VULGARIS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223515,7/15/2014 15:55:17,,1323645349,7/15/2014 15:54:47,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,VERRUCA VULGARIS causes WART VIRUS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223515,7/15/2014 17:11:37,,1323722578,7/15/2014 17:10:53,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,WART VIRUS causes VERRUCA VULGARIS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223515,7/15/2014 18:54:52,,1323784788,7/15/2014 18:54:48,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,VERRUCA VULGARIS causes WART VIRUS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223515,7/15/2014 21:30:31,,1323851609,7/15/2014 21:29:58,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,WART VIRUS causes VERRUCA VULGARIS,89,16,,98,32,causes,1,903573-FS1-4,In 243 cases of VERRUCA VULGARIS about 85% of the epidermal efflorescences caused by the WART VIRUS were cured by two or more applications of Solcoderm in ambulant therapy.,WART VIRUS,VERRUCA VULGARIS,RO-has_causative_agent
503223516,7/15/2014 10:12:19,,1323477814,7/15/2014 10:11:31,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223516,7/15/2014 10:31:31,,1323490225,7/15/2014 10:31:01,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223516,7/15/2014 12:56:21,,1323568172,7/15/2014 12:55:57,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223516,7/15/2014 14:21:49,,1323595769,7/15/2014 14:21:23,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223516,7/15/2014 14:33:49,,1323599433,7/15/2014 14:33:43,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223516,7/15/2014 16:52:15,,1323703329,7/15/2014 16:51:45,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223516,7/15/2014 17:55:27,,1323758177,7/15/2014 17:55:13,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.981980506061966,907821-FS1-2,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
503223517,7/15/2014 10:31:31,,1323490220,7/15/2014 10:31:01,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,ESOPHAGEAL TUMOR is location of MIDDLE AND LOWER ESOPHAGUS,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223517,7/15/2014 11:55:18,,1323544413,7/15/2014 11:55:05,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,MIDDLE AND LOWER ESOPHAGUS is location of ESOPHAGEAL TUMOR,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223517,7/15/2014 13:07:08,,1323572474,7/15/2014 13:07:00,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,MIDDLE AND LOWER ESOPHAGUS is location of ESOPHAGEAL TUMOR,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223517,7/15/2014 14:33:42,,1323599397,7/15/2014 14:33:36,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,ESOPHAGEAL TUMOR is location of MIDDLE AND LOWER ESOPHAGUS,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223517,7/15/2014 15:16:40,,1323617696,7/15/2014 15:15:58,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,MIDDLE AND LOWER ESOPHAGUS is location of ESOPHAGEAL TUMOR,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223517,7/15/2014 16:24:36,,1323670858,7/15/2014 16:24:26,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223517,7/15/2014 16:49:58,,1323700857,7/15/2014 16:49:25,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,MIDDLE AND LOWER ESOPHAGUS is location of ESOPHAGEAL TUMOR,70,4,,95,20,is location of,0.983869910099907,905417-FS1-9,The ESOPHAGEAL TUMOR showed a fungating growth at the junction of the MIDDLE AND LOWER ESOPHAGUS and was composed microscopically of submucosal multiple nests with solid and cribriform like patterns accompanied with a small focus of squamous cell carcinoma adjacent to the overlying esophageal epithelium.,MIDDLE AND LOWER ESOPHAGUS,ESOPHAGEAL TUMOR,RO-has_finding_site
503223518,7/15/2014 10:31:20,,1323490091,7/15/2014 10:31:01,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223518,7/15/2014 10:55:52,,1323506983,7/15/2014 10:55:30,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,HEADACHE TREATMENTS causes MIGRAINE DIAGNOSIS,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223518,7/15/2014 11:26:43,,1323527537,7/15/2014 11:26:17,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,MIGRAINE DIAGNOSIS causes HEADACHE TREATMENTS,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223518,7/15/2014 12:55:28,,1323567788,7/15/2014 12:54:59,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223518,7/15/2014 15:49:15,,1323640714,7/15/2014 15:48:54,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,MIGRAINE DIAGNOSIS causes HEADACHE TREATMENTS,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223518,7/15/2014 15:54:49,,1323644967,7/15/2014 15:54:33,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223518,7/15/2014 16:58:25,,1323710185,7/15/2014 16:58:13,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,MIGRAINE DIAGNOSIS causes HEADACHE TREATMENTS,105,73,,123,91,causes,0.353553390593274,904719-FS1-4,"Migraine patients underwent a structured direct interview about previous MIGRAINE DIAGNOSIS comorbidity, HEADACHE TREATMENTS and their side effects and healthcare utilization for migraine.",HEADACHE TREATMENTS,MIGRAINE DIAGNOSIS,RO-has_definitional_manifestation
503223519,7/15/2014 12:40:42,,1323561958,7/15/2014 12:40:33,instagc,0.7417,18960682,GBR,"","",86.29.147.112,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 13:03:42,,1323571256,7/15/2014 13:03:06,prodege,0.875,19192508,USA,OK,Broken Arrow,70.177.111.89,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 15:24:13,,1323622383,7/15/2014 15:23:49,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 16:25:10,,1323671557,7/15/2014 16:24:55,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 16:53:53,,1323704964,7/15/2014 16:53:44,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 17:00:57,,1323713197,7/15/2014 17:00:45,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 17:24:18,,1323729405,7/15/2014 17:23:47,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.943456353049726,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223520,7/15/2014 10:52:41,,1323504945,7/15/2014 10:52:32,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,METASTATIC LESION OF THE SKULL causes BONE METASTASES,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223520,7/15/2014 13:07:20,,1323572555,7/15/2014 13:07:11,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,METASTATIC LESION OF THE SKULL causes BONE METASTASES,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223520,7/15/2014 16:47:17,,1323697938,7/15/2014 16:47:08,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,METASTATIC LESION OF THE SKULL causes BONE METASTASES,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223520,7/15/2014 17:23:41,,1323729123,7/15/2014 17:23:13,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,BONE METASTASES causes METASTATIC LESION OF THE SKULL,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223520,7/15/2014 17:55:52,,1323758674,7/15/2014 17:55:28,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,BONE METASTASES causes METASTATIC LESION OF THE SKULL,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223520,7/15/2014 19:22:43,,1323799408,7/15/2014 19:22:09,clixsense,0.4583,11338264,CAN,ON,Aurora,184.148.114.225,BONE METASTASES causes METASTATIC LESION OF THE SKULL,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223520,7/15/2014 20:35:32,,1323828655,7/15/2014 20:34:36,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,BONE METASTASES causes METASTATIC LESION OF THE SKULL,44,24,,73,39,causes,0.565685424949238,901939-FS1-4,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223521,7/15/2014 10:56:48,,1323507505,7/15/2014 10:55:54,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,INVOLVEMENT OF THE SKIN AND MUCOSA causes DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223521,7/15/2014 11:25:41,,1323526997,7/15/2014 11:25:23,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) causes INVOLVEMENT OF THE SKIN AND MUCOSA,159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223521,7/15/2014 12:41:55,,1323562414,7/15/2014 12:41:42,instagc,0.7417,18960682,GBR,"","",86.29.147.112,no_relation,159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223521,7/15/2014 13:58:30,,1323589234,7/15/2014 13:57:42,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) causes INVOLVEMENT OF THE SKIN AND MUCOSA,159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223521,7/15/2014 16:56:52,,1323708361,7/15/2014 16:56:34,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,INVOLVEMENT OF THE SKIN AND MUCOSA causes DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223521,7/15/2014 22:40:10,,1323881158,7/15/2014 22:40:03,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223521,7/16/2014 00:41:18,,1323946418,7/16/2014 00:40:33,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) causes INVOLVEMENT OF THE SKIN AND MUCOSA,159,66,,192,125,causes,0.883452208598772,902277-FS1-4,Clinical and laboratory examinations of 250 patients with chronic DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC) have revealed secondary candidal INVOLVEMENT OF THE SKIN AND MUCOSA in 121 (46.6%.,INVOLVEMENT OF THE SKIN AND MUCOSA,DERMATOSES (ECZEMA NEURODERMATITIS PSORIASIS PEMPHIGUS ETC),RO-disease_has_primary_anatomic_site
503223522,7/15/2014 11:01:17,,1323510225,7/15/2014 11:00:49,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,ALCOHOLIC CIRRHOSIS causes END STAGE LIVER DISEASE,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223522,7/15/2014 11:25:41,,1323527006,7/15/2014 11:25:23,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,ALCOHOLIC CIRRHOSIS causes END STAGE LIVER DISEASE,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223522,7/15/2014 11:33:03,,1323531189,7/15/2014 11:32:36,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,ALCOHOLIC CIRRHOSIS causes END STAGE LIVER DISEASE,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223522,7/15/2014 12:39:40,,1323561659,7/15/2014 12:39:23,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,ALCOHOLIC CIRRHOSIS causes END STAGE LIVER DISEASE,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223522,7/15/2014 13:07:20,,1323572551,7/15/2014 13:07:11,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,no_relation,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223522,7/15/2014 15:43:56,,1323636768,7/15/2014 15:43:30,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,ALCOHOLIC CIRRHOSIS causes END STAGE LIVER DISEASE,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223522,7/15/2014 16:24:54,,1323671157,7/15/2014 16:24:37,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,ALCOHOLIC CIRRHOSIS causes END STAGE LIVER DISEASE,104,152,,126,171,causes,0.995893206467704,902320-FS1-4,"SEE:   liver    liver transplantation    The surgical implantation of a donor liver into a patient with END STAGE LIVER DISEASE whether it is caused by ALCOHOLIC CIRRHOSIS chronic cholestatic diseases, chronic or fulminant hepatitis, or toxic liver destruction.",END STAGE LIVER DISEASE,ALCOHOLIC CIRRHOSIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 11:55:02,,1323544277,7/15/2014 11:54:48,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,REFLUX TO THE STOMACH causes PATHOGENESIS OF RESIDUAL GASTRITIS,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 12:39:22,,1323561570,7/15/2014 12:38:58,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 13:07:08,,1323572486,7/15/2014 13:07:00,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,no_relation,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 15:25:17,,1323623034,7/15/2014 15:24:49,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,REFLUX TO THE STOMACH causes PATHOGENESIS OF RESIDUAL GASTRITIS,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 16:50:50,,1323701798,7/15/2014 16:49:59,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,REFLUX TO THE STOMACH causes PATHOGENESIS OF RESIDUAL GASTRITIS,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 16:58:12,,1323709921,7/15/2014 16:58:03,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,REFLUX TO THE STOMACH causes PATHOGENESIS OF RESIDUAL GASTRITIS,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223523,7/15/2014 17:15:33,,1323725003,7/15/2014 17:14:59,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,PATHOGENESIS OF RESIDUAL GASTRITIS causes REFLUX TO THE STOMACH,5,63,,25,97,causes,0.657595949221429,902170-FS1-4,Bile REFLUX TO THE STOMACH is believed as one of the important PATHOGENESIS OF RESIDUAL GASTRITIS however the prevention for bile reflux cannot always heal the gastritis.,REFLUX TO THE STOMACH,PATHOGENESIS OF RESIDUAL GASTRITIS,RO-disease_has_primary_anatomic_site
503223524,7/15/2014 11:35:41,,1323532788,7/15/2014 11:35:17,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223524,7/15/2014 15:19:15,,1323619050,7/15/2014 15:18:46,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223524,7/15/2014 16:54:05,,1323705148,7/15/2014 16:53:54,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223524,7/15/2014 19:37:26,,1323805689,7/15/2014 19:37:06,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223524,7/15/2014 22:40:10,,1323881151,7/15/2014 22:40:03,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223524,7/16/2014 00:46:20,,1323948683,7/16/2014 00:45:46,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223524,7/16/2014 01:45:35,,1323980306,7/16/2014 01:45:23,clixsense,0.7798,19638651,USA,"","",173.23.121.63,BUSULPHAN treats POLYCYTHAEMIA VERA,17,58,,34,67,treats,0.979957887012223,907742-FS1-2,1]  Treatment of POLYCYTHAEMIA VERA by radiophosphorus or BUSULPHAN: a randomized trial.,POLYCYTHAEMIA VERA,BUSULPHAN,RO-may_treat
503223525,7/15/2014 11:54:03,,1323543919,7/15/2014 11:53:45,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,NEUROFIBROMATOSIS is location of NERVOUS SYSTEM,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 15:23:28,,1323621892,7/15/2014 15:23:06,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 17:11:37,,1323722577,7/15/2014 17:10:53,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 19:36:06,,1323805154,7/15/2014 19:35:45,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 21:32:42,,1323852419,7/15/2014 21:32:22,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/16/2014 00:37:34,,1323944688,7/16/2014 00:36:32,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/16/2014 01:09:03,,1323962087,7/16/2014 01:08:42,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,no_relation,108,0,,121,17,is location of,0.755928946018454,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223526,7/15/2014 11:17:20,,1323522235,7/15/2014 11:16:44,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,REENTRANT ARRHYTHMIAS diagnosed by ANTIARRHYTHMIC DRUGS,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223526,7/15/2014 12:41:41,,1323562286,7/15/2014 12:41:17,instagc,0.7417,18960682,GBR,"","",86.29.147.112,no_relation,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223526,7/15/2014 12:43:07,,1323562856,7/15/2014 12:42:45,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223526,7/15/2014 14:24:03,,1323596449,7/15/2014 14:23:21,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223526,7/15/2014 15:47:39,,1323639542,7/15/2014 15:47:21,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,REENTRANT ARRHYTHMIAS diagnosed by ANTIARRHYTHMIC DRUGS,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223526,7/15/2014 15:54:15,,1323644520,7/15/2014 15:53:40,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,REENTRANT ARRHYTHMIAS diagnosed by ANTIARRHYTHMIC DRUGS,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223526,7/15/2014 17:56:16,,1323759060,7/15/2014 17:55:53,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,REENTRANT ARRHYTHMIAS diagnosed by ANTIARRHYTHMIC DRUGS,54,130,,74,150,diagnosed by,0.862662185627507,907439-FS1-13,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
503223527,7/15/2014 10:57:31,,1323507902,7/15/2014 10:56:50,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,EDEMA diagnosed by BUMETANIDE,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223527,7/15/2014 11:24:30,,1323526417,7/15/2014 11:24:14,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223527,7/15/2014 12:16:46,,1323552973,7/15/2014 12:16:14,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,BUMETANIDE diagnosed by EDEMA,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223527,7/15/2014 16:25:10,,1323671558,7/15/2014 16:24:55,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223527,7/15/2014 18:50:45,,1323782572,7/15/2014 18:50:41,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223527,7/15/2014 19:37:04,,1323805546,7/15/2014 19:36:47,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,EDEMA diagnosed by BUMETANIDE,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223527,7/15/2014 21:32:21,,1323852289,7/15/2014 21:31:45,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,EDEMA diagnosed by BUMETANIDE,70,87,,74,97,diagnosed by,0.375,908056-FS1-13,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223528,7/15/2014 10:30:04,,1323489199,7/15/2014 10:29:51,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 11:23:41,,1323525904,7/15/2014 11:23:07,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 11:54:33,,1323544095,7/15/2014 11:54:17,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,FEVER causes INFECTIOUS MONONUCLEOSIS,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 13:35:58,,1323582388,7/15/2014 13:35:45,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 16:54:22,,1323705469,7/15/2014 16:54:06,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 18:45:32,,1323779808,7/15/2014 18:44:27,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 19:13:02,,1323794636,7/15/2014 19:12:39,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.970142500145332,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223529,7/15/2014 10:10:15,,1323476701,7/15/2014 10:09:26,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 10:11:30,,1323477321,7/15/2014 10:10:56,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 11:17:11,,1323522081,7/15/2014 11:16:27,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 13:07:57,,1323572722,7/15/2014 13:07:49,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,METASTATIC LESIONS causes PULMONARY METASTASES,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 16:46:49,,1323697377,7/15/2014 16:46:42,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,METASTATIC LESIONS causes PULMONARY METASTASES,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 19:36:46,,1323805444,7/15/2014 19:36:23,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 22:40:17,,1323881184,7/15/2014 22:40:11,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,41,117,,58,137,causes,0.993127066322841,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223530,7/15/2014 10:32:01,,1323490514,7/15/2014 10:31:36,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,PV causes THROMBOSIS,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 10:33:58,,1323491773,7/15/2014 10:33:20,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 11:27:40,,1323528164,7/15/2014 11:27:27,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 15:54:32,,1323644771,7/15/2014 15:54:16,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,PV causes THROMBOSIS,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 15:56:23,,1323646174,7/15/2014 15:55:50,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,PV causes THROMBOSIS,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 16:46:57,,1323697642,7/15/2014 16:46:50,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,THROMBOSIS causes PV,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 16:52:22,,1323703469,7/15/2014 16:51:57,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223531,7/15/2014 10:31:39,,1323490296,7/15/2014 10:31:20,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 11:18:18,,1323522884,7/15/2014 11:17:46,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 14:34:03,,1323599520,7/15/2014 14:33:58,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 17:15:33,,1323725004,7/15/2014 17:14:59,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,IRON contraindicates HEMOCHROMATOSIS,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 17:57:49,,1323760648,7/15/2014 17:57:32,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 18:54:47,,1323784752,7/15/2014 18:54:44,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 19:54:52,,1323812034,7/15/2014 19:54:17,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,IRON contraindicates HEMOCHROMATOSIS,51,94,,65,98,contraindicates,0.697485832462916,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223532,7/15/2014 10:11:39,,1323477407,7/15/2014 10:11:11,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,ATOPIC CONDITIONS causes ALLERGIC CONJUNCTIVITIS,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223532,7/15/2014 11:22:41,,1323525284,7/15/2014 11:22:01,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223532,7/15/2014 15:54:32,,1323644770,7/15/2014 15:54:16,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223532,7/15/2014 16:46:41,,1323697236,7/15/2014 16:46:29,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,ATOPIC CONDITIONS causes ALLERGIC CONJUNCTIVITIS,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223532,7/15/2014 17:10:07,,1323721493,7/15/2014 17:09:42,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,ATOPIC CONDITIONS causes ALLERGIC CONJUNCTIVITIS,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223532,7/15/2014 17:16:03,,1323725233,7/15/2014 17:15:38,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,no_relation,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223532,7/16/2014 00:44:40,,1323947892,7/16/2014 00:44:02,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,60,0,,82,17,causes,0.50709255283711,900211-FS1-4,"ATOPIC CONDITIONS include allergic rhinitis, atopic eczema, ALLERGIC CONJUNCTIVITIS and asthma.",ALLERGIC CONJUNCTIVITIS,ATOPIC CONDITIONS,RO-cause_of
503223533,7/15/2014 12:41:15,,1323562156,7/15/2014 12:40:55,instagc,0.7417,18960682,GBR,"","",86.29.147.112,no_relation,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223533,7/15/2014 12:54:58,,1323567632,7/15/2014 12:54:38,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,NEUROFIBROMATOSIS TYPE 1 causes CONGENITAL PSEUDARTHROSIS OF THE ULNA,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223533,7/15/2014 13:55:30,,1323588318,7/15/2014 13:54:33,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223533,7/15/2014 14:33:35,,1323599370,7/15/2014 14:33:30,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,NEUROFIBROMATOSIS TYPE 1 causes CONGENITAL PSEUDARTHROSIS OF THE ULNA,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223533,7/15/2014 15:54:15,,1323644521,7/15/2014 15:53:40,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,NEUROFIBROMATOSIS TYPE 1 causes CONGENITAL PSEUDARTHROSIS OF THE ULNA,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223533,7/15/2014 16:53:42,,1323704765,7/15/2014 16:53:07,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,CONGENITAL PSEUDARTHROSIS OF THE ULNA causes NEUROFIBROMATOSIS TYPE 1,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223533,7/15/2014 17:01:33,,1323713725,7/15/2014 17:01:19,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,NEUROFIBROMATOSIS TYPE 1 causes CONGENITAL PSEUDARTHROSIS OF THE ULNA,71,18,,107,42,causes,0.512147519731584,906339-FS1-4,Two children with NEUROFIBROMATOSIS TYPE 1 who presented at birth with CONGENITAL PSEUDARTHROSIS OF THE ULNA and radius are described.,CONGENITAL PSEUDARTHROSIS OF THE ULNA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
503223534,7/15/2014 12:54:58,,1323567633,7/15/2014 12:54:38,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,LEFLUNOMIDE contraindicates PREGNANCY,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223534,7/15/2014 15:45:19,,1323637872,7/15/2014 15:44:49,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,PREGNANCY contraindicates LEFLUNOMIDE,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223534,7/15/2014 16:24:25,,1323670649,7/15/2014 16:24:15,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223534,7/15/2014 19:54:16,,1323811868,7/15/2014 19:53:35,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,LEFLUNOMIDE contraindicates PREGNANCY,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223534,7/15/2014 20:25:38,,1323824490,7/15/2014 20:24:43,clixsense,0.5208,25399403,GBR,"","",188.29.96.57,PREGNANCY contraindicates LEFLUNOMIDE,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223534,7/15/2014 20:33:55,,1323828039,7/15/2014 20:32:44,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,LEFLUNOMIDE contraindicates PREGNANCY,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223534,7/16/2014 00:46:49,,1323948929,7/16/2014 00:46:21,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,LEFLUNOMIDE contraindicates PREGNANCY,73,12,,81,23,contraindicates,0.857142857142857,901397-FS1-10,Discontinue LEFLUNOMIDE if the drug is administered inadvertently during PREGNANCY or if the patient becomes pregnant while receiving the drug.,PREGNANCY,LEFLUNOMIDE,RO-contraindicated_drug
503223535,7/15/2014 10:30:56,,1323489771,7/15/2014 10:30:33,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,THIAMINE (VITAMIN B1 DEFICIENCY causes WERNICKE'S ENCEPHALOPATHY,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223535,7/15/2014 11:16:09,,1323521347,7/15/2014 11:15:30,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223535,7/15/2014 11:18:32,,1323523014,7/15/2014 11:18:00,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223535,7/15/2014 11:34:18,,1323532014,7/15/2014 11:33:54,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223535,7/15/2014 13:55:10,,1323588219,7/15/2014 13:54:44,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,THIAMINE (VITAMIN B1 DEFICIENCY causes WERNICKE'S ENCEPHALOPATHY,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223535,7/15/2014 15:55:33,,1323645525,7/15/2014 15:55:11,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,WERNICKE'S ENCEPHALOPATHY causes THIAMINE (VITAMIN B1 DEFICIENCY,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223535,7/15/2014 15:55:48,,1323645714,7/15/2014 15:55:19,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,THIAMINE (VITAMIN B1 DEFICIENCY causes WERNICKE'S ENCEPHALOPATHY,91,42,,115,73,causes,0.875189948987367,908170-FS1-4,"Metabolic dysfunction as a consequence of THIAMINE (VITAMIN B1 DEFICIENCY (TD), a model of WERNICKE'S ENCEPHALOPATHY leads to elevation of extracellular glutamate concentration in vulnerable brain regions consistent with the development of excitotoxicity.",WERNICKE'S ENCEPHALOPATHY,THIAMINE (VITAMIN B1 DEFICIENCY,RO-may_treat
503223536,7/15/2014 10:26:52,,1323487008,7/15/2014 10:26:17,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 10:53:04,,1323505176,7/15/2014 10:52:55,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:16:42,,1323521671,7/15/2014 11:16:11,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:18:32,,1323523019,7/15/2014 11:18:00,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:23:25,,1323525758,7/15/2014 11:23:01,instagc,0.9417,13763729,USA,"","",75.182.89.225,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:24:07,,1323526203,7/15/2014 11:23:42,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 12:40:50,,1323562008,7/15/2014 12:39:41,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223537,7/15/2014 10:30:04,,1323489200,7/15/2014 10:29:51,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,DYSENTERY causes DIARRHEA,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223537,7/15/2014 10:34:30,,1323492081,7/15/2014 10:33:59,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223537,7/15/2014 11:18:45,,1323523154,7/15/2014 11:18:34,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223537,7/15/2014 11:40:53,,1323535739,7/15/2014 11:40:20,clixsense,0.5,23233834,GBR,N6,Sunderland,86.17.58.181,no_relation,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223537,7/15/2014 12:43:29,,1323562987,7/15/2014 12:43:09,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223537,7/15/2014 13:54:35,,1323588092,7/15/2014 13:54:16,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,DYSENTERY causes DIARRHEA,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223537,7/15/2014 15:47:39,,1323639544,7/15/2014 15:47:21,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,DIARRHEA causes DYSENTERY,16,60,,23,69,causes,0.809039834955891,904873-FS1-4,"Each episode of DIARRHEA lasted a mean of 3 d, and those of DYSENTERY and ARI, 5 d.",DIARRHEA,DYSENTERY,RO-has_definitional_manifestation
503223538,7/15/2014 10:10:55,,1323477054,7/15/2014 10:10:34,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 11:25:02,,1323526697,7/15/2014 11:24:09,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 11:51:40,,1323542249,7/15/2014 11:51:24,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 14:24:56,,1323596657,7/15/2014 14:24:11,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 15:48:30,,1323640144,7/15/2014 15:48:03,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,ISLET CELLS diagnosed by DIABETES,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 15:55:17,,1323645348,7/15/2014 15:54:47,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 16:54:22,,1323705471,7/15/2014 16:54:06,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.771516749810459,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223539,7/15/2014 10:31:19,,1323490076,7/15/2014 10:30:44,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,no_relation,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 11:19:15,,1323523504,7/15/2014 11:18:46,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 12:40:50,,1323562006,7/15/2014 12:39:41,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 14:22:12,,1323595834,7/15/2014 14:21:50,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 15:56:50,,1323646498,7/15/2014 15:56:25,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 17:58:45,,1323761193,7/15/2014 17:58:25,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 18:45:32,,1323779807,7/15/2014 18:44:27,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,no_relation,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223540,7/15/2014 10:30:20,,1323489343,7/15/2014 10:30:13,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,BOVINE TUBERCULOSIS (BTB) causes MYCOBACTERIUM BOVIS,76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 10:32:01,,1323490513,7/15/2014 10:31:36,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 11:23:41,,1323525903,7/15/2014 11:23:07,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 13:34:24,,1323581838,7/15/2014 13:34:06,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,BOVINE TUBERCULOSIS (BTB) causes MYCOBACTERIUM BOVIS,76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 15:32:41,,1323628397,7/15/2014 15:32:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 16:56:52,,1323708375,7/15/2014 16:56:34,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 18:54:57,,1323784829,7/15/2014 18:54:53,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.949157995752499,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223541,7/15/2014 10:12:11,,1323477726,7/15/2014 10:11:40,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,DIABETES causes ISLET CELLS,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223541,7/15/2014 10:12:40,,1323477972,7/15/2014 10:12:20,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,ISLET CELLS causes DIABETES,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223541,7/15/2014 11:27:06,,1323527789,7/15/2014 11:26:45,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223541,7/15/2014 13:06:56,,1323572412,7/15/2014 13:06:44,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,DIABETES causes ISLET CELLS,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223541,7/15/2014 14:23:15,,1323596116,7/15/2014 14:22:51,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223541,7/15/2014 22:40:27,,1323881235,7/15/2014 22:40:18,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223541,7/16/2014 00:46:20,,1323948682,7/16/2014 00:45:46,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,100,155,,110,163,causes,0.308606699924184,902036-FS1-4,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:12:47,,1323478036,7/15/2014 10:12:12,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:30:03,,1323489195,7/15/2014 10:29:55,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:32:00,,1323490517,7/15/2014 10:31:40,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:56:48,,1323507504,7/15/2014 10:55:54,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,ISLET CELL TUMORS is location of ISLET CELLS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 11:54:03,,1323543939,7/15/2014 11:53:45,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,ISLET CELL TUMORS is location of ISLET CELLS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 13:36:14,,1323582461,7/15/2014 13:36:01,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 15:43:56,,1323636782,7/15/2014 15:43:30,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,ISLET CELL TUMORS is location of ISLET CELLS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223543,7/15/2014 10:33:19,,1323491331,7/15/2014 10:32:37,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,OBESITY causes SEVERE OBESITY,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223543,7/15/2014 12:56:37,,1323568271,7/15/2014 12:56:22,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,OBESITY causes SEVERE OBESITY,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223543,7/15/2014 16:57:23,,1323708996,7/15/2014 16:56:53,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,SEVERE OBESITY causes OBESITY,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223543,7/15/2014 21:32:57,,1323852461,7/15/2014 21:32:42,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223543,7/15/2014 22:16:05,,1323869313,7/15/2014 22:15:41,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,OBESITY causes SEVERE OBESITY,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223543,7/15/2014 22:41:53,,1323881804,7/15/2014 22:41:45,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223543,7/16/2014 00:38:28,,1323945068,7/16/2014 00:37:35,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,OBESITY causes SEVERE OBESITY,176,169,,182,183,causes,0.428571428571429,904974-FS1-4,"Investigation of the developmental course through the school ages and distributional changes over time among school children suggests that the increase in prevalence of SEVERE OBESITY among young men is due to an increased persistence of OBESITY through adolescence, which parallels the development of welfare conditions in this country.",OBESITY,SEVERE OBESITY,RO-has_definitional_manifestation
503223544,7/15/2014 11:34:11,,1323531917,7/15/2014 11:33:42,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 11:51:06,,1323541797,7/15/2014 11:50:40,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,WALDENSTROM'S MACROGLOBULINEMIA causes HYPERVISCOSITY,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 11:54:33,,1323544094,7/15/2014 11:54:17,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,WALDENSTROM'S MACROGLOBULINEMIA causes HYPERVISCOSITY,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 12:14:57,,1323552351,7/15/2014 12:14:26,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,HYPERVISCOSITY causes WALDENSTROM'S MACROGLOBULINEMIA,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 12:40:42,,1323561959,7/15/2014 12:40:33,instagc,0.7417,18960682,GBR,"","",86.29.147.112,no_relation,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 14:15:38,,1323593874,7/15/2014 14:15:21,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 16:24:15,,1323670438,7/15/2014 16:23:59,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,WALDENSTROM'S MACROGLOBULINEMIA causes HYPERVISCOSITY,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223545,7/15/2014 10:10:39,,1323476916,7/15/2014 10:10:16,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 11:10:02,,1323517349,7/15/2014 11:09:26,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 11:21:59,,1323524986,7/15/2014 11:21:38,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 13:33:50,,1323581658,7/15/2014 13:33:36,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 13:56:44,,1323588759,7/15/2014 13:55:41,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 22:15:40,,1323869113,7/15/2014 22:15:25,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,ULCERATIVE COLITIS treats MESALAMINE,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/16/2014 01:08:41,,1323961871,7/16/2014 01:08:24,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223546,7/15/2014 16:25:23,,1323671767,7/15/2014 16:25:11,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/15/2014 18:50:45,,1323782571,7/15/2014 18:50:41,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,LIVER causes LIVER FAILURE,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/15/2014 20:25:38,,1323824481,7/15/2014 20:24:43,clixsense,0.5208,25399403,GBR,"","",188.29.96.57,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/15/2014 20:36:35,,1323829056,7/15/2014 20:35:33,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/16/2014 01:08:23,,1323961669,7/16/2014 01:07:59,bitcoinget,0.6825,28377798,GBR,"","",195.166.117.126,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/16/2014 01:36:36,,1323977065,7/16/2014 01:35:59,clixsense,0.5345,6574199,USA,NJ,Mount Laurel,72.82.165.96,LIVER causes LIVER FAILURE,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/16/2014 01:44:06,,1323979744,7/16/2014 01:43:46,clixsense,0.7798,19638651,USA,"","",173.23.121.63,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223547,7/15/2014 10:27:30,,1323487449,7/15/2014 10:27:21,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,ACUTE TOLERANCE diagnosed by DRUG NAIVE ANIMALS,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 10:28:30,,1323488251,7/15/2014 10:27:39,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,DRUG NAIVE ANIMALS diagnosed by ACUTE TOLERANCE,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 10:31:00,,1323489832,7/15/2014 10:30:32,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,DRUG NAIVE ANIMALS diagnosed by ACUTE TOLERANCE,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 11:17:42,,1323522490,7/15/2014 11:17:12,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,DRUG NAIVE ANIMALS diagnosed by ACUTE TOLERANCE,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 11:24:50,,1323526605,7/15/2014 11:24:31,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 11:33:27,,1323531430,7/15/2014 11:33:04,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 13:15:09,,1323575227,7/15/2014 13:14:18,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,ACUTE TOLERANCE diagnosed by DRUG NAIVE ANIMALS,109,40,,126,55,diagnosed by,0.762492851663023,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223548,7/15/2014 11:22:33,,1323525215,7/15/2014 11:22:07,instagc,0.9417,13763729,USA,"","",75.182.89.225,SERUM DIGOXIN CONCENTRATION causes SUICIDAL DIGOXIN POISONING,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 17:10:50,,1323722048,7/15/2014 17:10:08,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,SERUM DIGOXIN CONCENTRATION causes SUICIDAL DIGOXIN POISONING,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 17:23:09,,1323728820,7/15/2014 17:22:42,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 18:50:54,,1323782642,7/15/2014 18:50:50,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,SERUM DIGOXIN CONCENTRATION causes SUICIDAL DIGOXIN POISONING,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 19:42:04,,1323807733,7/15/2014 19:41:44,clixsense,0.6984,24429778,AUS,"","",121.211.19.218,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 20:37:13,,1323829342,7/15/2014 20:36:36,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 21:32:21,,1323852278,7/15/2014 21:31:45,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.702246883176783,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223549,7/15/2014 11:17:59,,1323522675,7/15/2014 11:17:43,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,PITUITARY ADENOMAS causes TUBERCULOUS INVOLVEMENT OF PITUITARY,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 11:40:19,,1323535442,7/15/2014 11:39:53,clixsense,0.5,23233834,GBR,N6,Sunderland,86.17.58.181,TUBERCULOUS INVOLVEMENT OF PITUITARY causes PITUITARY ADENOMAS,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 13:56:04,,1323588494,7/15/2014 13:55:43,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PITUITARY ADENOMAS causes TUBERCULOUS INVOLVEMENT OF PITUITARY,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 15:56:23,,1323646173,7/15/2014 15:55:50,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 16:53:06,,1323704138,7/15/2014 16:52:23,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,PITUITARY ADENOMAS causes TUBERCULOUS INVOLVEMENT OF PITUITARY,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 17:09:41,,1323721165,7/15/2014 17:09:16,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 17:14:50,,1323724648,7/15/2014 17:14:20,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,no_relation,0,103,,35,121,causes,0.348155311911396,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223550,7/15/2014 11:22:33,,1323525214,7/15/2014 11:22:07,instagc,0.9417,13763729,USA,"","",75.182.89.225,BRAIN is location of STROKE,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223550,7/15/2014 11:34:52,,1323532314,7/15/2014 11:34:20,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,BRAIN is location of STROKE,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223550,7/15/2014 12:55:55,,1323567999,7/15/2014 12:55:30,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,BRAIN is location of STROKE,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223550,7/15/2014 15:44:48,,1323637487,7/15/2014 15:44:19,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,BRAIN is location of STROKE,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223550,7/15/2014 18:54:52,,1323784790,7/15/2014 18:54:48,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,BRAIN is location of STROKE,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223550,7/15/2014 19:34:09,,1323804299,7/15/2014 19:33:56,gifthulk,0.6774,21916793,GBR,"","",87.113.87.199,BRAIN is location of STROKE,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223550,7/15/2014 19:52:47,,1323811334,7/15/2014 19:52:04,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,156,166,,160,172,is location of,0.808290376865476,902102-FS1-9,"The restoration of blood flow to a part of the body previously deprived of adequate circulation, such as the heart muscle (in myocardial infarction) or the BRAIN (in STROKE",BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503223551,7/15/2014 11:27:25,,1323527996,7/15/2014 11:27:07,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,ORAL ANTIFUNGAL (EG KETOCONAZOLE) treats CUTANEOUS OR PULMONARY BLASTOMYCOSIS,115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223551,7/15/2014 13:34:49,,1323581930,7/15/2014 13:34:27,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,ORAL ANTIFUNGAL (EG KETOCONAZOLE) treats CUTANEOUS OR PULMONARY BLASTOMYCOSIS,115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223551,7/15/2014 15:23:48,,1323622077,7/15/2014 15:23:30,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,ORAL ANTIFUNGAL (EG KETOCONAZOLE) treats CUTANEOUS OR PULMONARY BLASTOMYCOSIS,115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223551,7/15/2014 17:58:23,,1323761004,7/15/2014 17:58:07,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,CUTANEOUS OR PULMONARY BLASTOMYCOSIS treats ORAL ANTIFUNGAL (EG KETOCONAZOLE),115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223551,7/15/2014 17:58:54,,1323761260,7/15/2014 17:58:43,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,ORAL ANTIFUNGAL (EG KETOCONAZOLE) treats CUTANEOUS OR PULMONARY BLASTOMYCOSIS,115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223551,7/15/2014 18:46:21,,1323780243,7/15/2014 18:45:34,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,ORAL ANTIFUNGAL (EG KETOCONAZOLE) treats CUTANEOUS OR PULMONARY BLASTOMYCOSIS,115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223551,7/16/2014 01:36:36,,1323977074,7/16/2014 01:35:59,clixsense,0.5345,6574199,USA,NJ,Mount Laurel,72.82.165.96,ORAL ANTIFUNGAL (EG KETOCONAZOLE) treats CUTANEOUS OR PULMONARY BLASTOMYCOSIS,115,52,,150,85,treats,1,907862-FS1-2,424   Treatment failures have been reported when an ORAL ANTIFUNGAL (EG KETOCONAZOLE) was used in the treatment of CUTANEOUS OR PULMONARY BLASTOMYCOSIS in patients who had asymptomatic or subclinical CNS involvement at the time of the initial diagnosis.,CUTANEOUS OR PULMONARY BLASTOMYCOSIS,ORAL ANTIFUNGAL (EG KETOCONAZOLE),RO-may_treat
503223552,7/15/2014 12:41:55,,1323562413,7/15/2014 12:41:42,instagc,0.7417,18960682,GBR,"","",86.29.147.112,SKIN is location of ECZEMA,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223552,7/15/2014 14:15:18,,1323593720,7/15/2014 14:14:49,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,SKIN is location of ECZEMA,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223552,7/15/2014 16:47:27,,1323698053,7/15/2014 16:47:19,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,ECZEMA is location of SKIN,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223552,7/15/2014 19:41:17,,1323807381,7/15/2014 19:40:54,clixsense,0.6984,24429778,AUS,"","",121.211.19.218,SKIN is location of ECZEMA,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223552,7/15/2014 19:54:16,,1323811866,7/15/2014 19:53:35,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223552,7/15/2014 22:40:43,,1323881323,7/15/2014 22:40:28,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,SKIN is location of ECZEMA,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223552,7/16/2014 00:47:23,,1323949201,7/16/2014 00:46:50,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,SKIN is location of ECZEMA,59,17,,62,23,is location of,0.964763821237732,902001-FS1-9,"All patients had ECZEMA on their hands; in addition, 4 had SKIN symptoms on airborne areas, i.e., wrists, neck and face.",SKIN,ECZEMA,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 11:24:13,,1323526256,7/15/2014 11:23:58,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 17:01:18,,1323713479,7/15/2014 17:00:58,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 17:57:13,,1323760041,7/15/2014 17:56:57,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,LIVER FAILURE is location of LIVER,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 17:58:21,,1323760971,7/15/2014 17:58:13,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 19:06:36,,1323791228,7/15/2014 19:05:56,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 19:22:43,,1323799396,7/15/2014 19:22:09,clixsense,0.4583,11338264,CAN,ON,Aurora,184.148.114.225,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 21:32:57,,1323852462,7/15/2014 21:32:42,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.938314863256836,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223554,7/15/2014 10:30:30,,1323489477,7/15/2014 10:30:21,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 10:34:30,,1323492092,7/15/2014 10:33:59,vivatic,0.7917,25451531,GBR,"","",83.67.28.193,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 15:19:15,,1323619049,7/15/2014 15:18:46,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 15:23:48,,1323622080,7/15/2014 15:23:30,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 16:52:33,,1323703646,7/15/2014 16:52:16,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 18:50:54,,1323782641,7/15/2014 18:50:50,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/16/2014 01:45:19,,1323980164,7/16/2014 01:45:00,clixsense,0.7798,19638651,USA,"","",173.23.121.63,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223555,7/15/2014 10:26:52,,1323487007,7/15/2014 10:26:17,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 11:18:50,,1323523235,7/15/2014 11:18:20,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 11:24:13,,1323526254,7/15/2014 11:23:58,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 14:12:43,,1323593113,7/15/2014 14:12:23,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 15:18:11,,1323618479,7/15/2014 15:17:35,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 15:31:39,,1323627609,7/15/2014 15:31:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 16:46:41,,1323697196,7/15/2014 16:46:29,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223556,7/15/2014 11:24:07,,1323526204,7/15/2014 11:23:42,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
503223556,7/15/2014 15:43:00,,1323636002,7/15/2014 15:42:43,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
503223556,7/15/2014 22:16:48,,1323869647,7/15/2014 22:16:36,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
503223556,7/16/2014 00:38:28,,1323945065,7/16/2014 00:37:35,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
503223556,7/16/2014 00:45:14,,1323948210,7/16/2014 00:44:41,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
503223556,7/16/2014 02:17:09,,1323995874,7/16/2014 02:16:54,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
503223556,7/16/2014 02:36:06,,1324003314,7/16/2014 02:35:38,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,OVERUSED JOINTS causes ARTHROSIS,116,83,,130,92,causes,0.883883476483184,902442-FS1-4,"In each case, abnormal biomechanics were caused by or associated with arthritis or ARTHROSIS due to advanced age or OVERUSED JOINTS",OVERUSED JOINTS,ARTHROSIS,RO-disease_has_primary_anatomic_site
